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Abstract 
 
Acetyl-CoA carboxylase (ACC) initiates the first committed step of fatty acid synthesis.  
ACC is composed of three separate components: biotin carboxylase (BC), 
carboxyltransferase (CT), and biotin carboxyl carrier protein (BCCP).  BC carries out the 
first half of the ACC reaction where it catalyzes the carboxylation of a biotin moiety 
covalently linked to the BCCP.  BC exists as a dimer but mutated versions of BC 
deficient in dimerization were reported to retain most of their enzymatic activity in vitro.  
I report that two different mutants severely deficient in their ability of form dimers are 
unable to complement growth as the sole source of BC unless expressed at very high 
levels.  The BC dimer mutants retained most of their activity in vitro even though their Kd 
had decreased hundreds fold.  I functionally replaced the endogenous accC with plasmids 
expressing either wild type or one of the dimer mutants.  While the dimer mutants were 
able to complement at high expression levels, they failed at the more modest levels which 
permitted growth with the wild type protein. Therefore BC must remain a dimer to fulfill 
its physiological function. 
 
CT carries out the second part of the ACC reaction where it transfers the biotin bound 
carboxyl group to acetyl-CoA in order to form malonyl-CoA which is destined for fatty 
acid synthesis.  CT consist of a heterotetramer of AccA and AccD which in E. coli are 
encoded by structural genes at the opposite ends of the chromosome.  Stoichiometric 
amounts of AccA and AccD are required and so the method to achieve this remains 
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unclear.  It was reported that the AccD subunit of CT is able to bind the transcripts of 
each subunit to allow for a degree of translational repression.  Long stretches (600 bp) of 
naked RNA were required to induce binding in vitro and so the plausibility of this 
method of regulation was questioned.  I have replicated these conditions in vivo using a 
multi plasmid dual promoter system which allows for measurement of subunit synthesis 
in the presence of varying quantities of CT tetramer.  I report that increased levels of CT 
tetramer have no effect on translation of the CT subunit mRNAs. 
 
The PII nitrogen regulation proteins from Arabidopsis were found to inhibit ACC activity 
in a manner sensitive to its natural substrate, 2-oxoglutarate (2-OG).  Given the close 
relation of plant plastid fatty acid synthetic enzymes and those in bacteria it was logical 
to test for this effect in E. coli.  I report that the E. coli PII protein GlnB causes inhibition 
of ACC activity which is then reversed by the addition of 2-OG.  The two PII proteins of 
E. coli, GlnB and GlnK, were purified and then tested for inhibition with overexpressed 
ACC cell extract. 
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Chapter One 
INTRODUCTION 
Membrane metabolism is an essential component of cellular life.  In bacteria the cell 
membrane provides the essential barrier between the cellular components and the 
external environment.  With the exception of archaea, fatty acids make up the majority of 
the membrane lipids.  Precious energy is devoted to maintaining membranes for growth 
or modification, the majority of which is spent through fatty acid biosynthesis.  In general 
fatty acid biosynthesis can be characterized into two major groups: The type I system 
found predominantly in mammals and fungi which utilize a single large polyfunctional 
enzyme carrying within it all the necessary residues and activities required to synthesize 
new fatty acids and the type II system, composed of separate enzyme and protein 
components.  The model organism for the type II system is Escherichia coli. Here 
discrete enzymes are used for each step of the pathway and in many cases multiple semi-
redundant enzymes are used in order to allow more specific regulation.  Tying these 
activities together in the type II system is the acyl carrier protein (ACP) which shuttles 
the intermediates between the individual reactions in order to provide a finished acyl 
chain product with which to incorporate into phospholipids.  All of the structural 
enzymes for fatty acid biosynthesis in Escherichia coli have been discovered and their 
activities purified and assayed. The initiator and rate determining step in fatty acid 
synthesis is the acetyl-CoA carboxylase (ACC) reaction. Although there is much 
information about these topics, the entirety of this area of study has still yet been 
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exhausted.  There are many questions remaining about enzyme structure, catalytic 
mechanisms, and methods of regulation. 
 
THE REACTIONS OF FATTY ACID BIOSYNTHESIS 
The fatty acid synthetic cycle begins with the acetyl-CoA carboxylase reaction.  This is 
known to be the first committed step as well as rate limiting to overall fatty acid synthesis 
[22].  Aspects of this reaction will be the main focus of this thesis.  In general the reaction 
takes acetyl-CoA along with free bicarbonate in order to generate malonyl-CoA, which is 
a building block for fatty acids and its sole destination in our model organism, 
Escherichia coli (Fig. 1.1). Once the requisite malonyl-CoA has been generated, the acyl 
chain is then transferred to an ACP molecule by malonyl-CoA-ACP transacylase 
(encoded by the gene fabD).  This transfer to ACP designates an acyl chain to be 
dedicated to fatty acid synthesis in contrast to longer acyl chain CoAs which are 
generally destined for the β-oxidation pathway of fatty acids. The initiation of the fatty 
acid synthetic cycle occurs when malonyl-ACP reacts with acetyl-CoA in a Claisen 
condensation reaction (Fig 1.2).  This initial condensation reaction is carried out by β-
ketoacyl-ACP (KAS III, encoded by the fabH gene).  There are three KAS enzymes but 
KAS III is the only one able to perform the initial condensation reaction and is 
predominant when the acyl chain involved is short (<6-8 carbons). There are two other 
methods of initiation: one involving the condensation of acetyl-ACP and malonyl-ACP 
and the other the decarboxylation of malonyl-ACP to acetyl-ACP which can then be 
condensed with malonyl-ACP.  This reaction generates a β-ketoester, in this instance 
acetoacetyl-ACP. The β-ketoester is then reduced by β-ketoacyl reductase (encoded by 
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fabG) to generate β-hydroxyacyl-ACP.  This is then dehydrated by β-hydroxyacyl-ACP 
dehydratase (encoded by fabZ) which yields a trans-2-acyl-ACP.  The final step within 
the cycle is the further reduction of enoyl-ACP to an acyl-ACP by enoyl-ACP reductase 
(encoded by fabI) [61].  This final reaction heavily favors product formation and is able 
to pull the cycle forward past the previous reductase and dehydratase reactions which are 
reversible [38].  The acyl-ACP generated is now two carbon chain lengths longer than the 
product that entered the cycle and is used again in the cycle to continue elongation until 
the desired chain length is attained and transferred to complex lipids. Further 
condensations beyond the short acyl chain length are carried out by either β-ketoacyl-
ACP synthase I (KAS I) or β-ketoacyl-ACP synthase II (KAS II) (encoded by fabB and 
fabF respectively)[33]. 
 
This is an example of the overlapping responsibilities present in the model type II fatty 
acid synthesis system. All three KAS enzymes perform condensation reactions but only 
KAS I and III are essential.  KASIII is essential because of its requirement for initiation 
and KASI for its role in long chain elongation and function at the branch point of 
unsaturated fatty acid synthesis. While non-essential, KAS II is required for the 
elongation of the 16 carbon substrate (palmitoyl-ACP) to the 18 carbon acyl chain (cis-
vaccenoyl-ACP) which allows for a degree of thermal regulation of membrane 
fluidity[32].  Also required for unsaturated fatty acid synthesis is β-hydroxyacyl-ACP 
dehydratase (encoded by fabA) which is dual function, performing a dehydratase reaction 
similar to FabZ, while also performing the isomerization reaction of trans-2-decenoyl-
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ACP to cis-3-decenoyl-ACP again at the branch point for the synthesis of unsaturated 
fatty acids[40]. 
 
DISCOVERY OF ACC ENZYMES AND GENES 
The bacterial multisubunit acetyl-CoA carboxylase is composed of three functional 
entities: biotin carboxylase (BC, AccC), biotin carboxyl carrier protein (BCCP, AccB) 
and carboxyltransferase (CT, AccA plus AccD), all of which are essential. The overall 
ACC reaction is carried out in two distinct half reactions.  The initial studies of ACC 
activity were isolated from mammalian liver as activity in a fraction containing the large 
polyfunctional enzyme and notably biotin [3]. These studies led to the proposal of a two 
part partial reactions. Alberts and Vagelos discovered the initial bacterial ACC activity in 
E. coli when they were able to isolate two separate fractions which allowed for each 
partial reaction with only one of the fractions containing biotin (Fig 1.1) [3]. Further 
studies led to the discovery that the biotin carboxyl carrier protein (BCCP, encoded by 
accB) was indeed the biotinylated protein in this reaction [2].  Purification of the biotin 
carboxylase (BC) and carboxyltransferase (CT) portions soon followed [2, 3, 27].  An 
early discovery that free biotin and related compounds could substitute for holo-BCCP 
allowed for more robust assays to be developed and a better understanding of the 
reactions and activities [35]. BC was then assayed as detailed later by the measure of 
incorporation of 14C label into carboxybiotin which is stable to exchange with unlabeled 
CO2 [35].  Also detailed later was how CT activity can be assayed in the reverse reaction 
in an ATP consuming reaction which measures the formation of NADH via 
spectrophotometry [35].   
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The genes of the four protein subunits of ACC have all been identified, cloned, 
overexpressed and assayed.  The genes encoding BCCP and BC were determined by 
Cronan and Li using hybridization experiments based on biotinylation experiments to 
isolate a chromosomal fragment containing accB, the BCCP structural gene [54].  This 
resulted in the discovery of the adjacent biotin carboxylase gene, accC and demonstrated 
that they constitute an operon.  Overexpression and protein sequence analysis confirmed 
that these were indeed the structural genes.  At the time the location and sequence of the 
carboxyltransferase genes were still unknown and surprisingly not included in the accBC 
operon.  Earlier data from purification had indicated that the CT was likely encoded by of 
two separate genes due to the differing sizes of protein resolved from the heterotetrameric 
full enzyme[54]. Peptide mapping also carried out by Li and Cronan revealed 
chromosomal fragments that hybridized to a deduced oligonucleotide sequence. The 
individual subunits were cloned and sequenced and named accA and accD (or renamed in 
the latter case for the previously sequenced dedB gene) for the alpha and beta subunits 
respectively.  Their mapping revealed that unlike the BC and BCCP operon the genes 
encoding the subunits of CT were well separated from one other and from the accBC 
locus.  The accD gene is located at minute 50 whereas the accA gene almost completely 
on the opposite side of the chromosome at minute 4.3 (Fig 1.4).  These are also separate 
from the accBC operon at minute 72. This genetic structure is found in both E. coli and 
Salmonella.  Most other bacterial organisms cluster all of the ACC genes together along 
with other fatty acid synthetic genes, often in a large operon.  Different still is the ACC 
genetic structure of plants which generally contain the dissociated type II fatty acid 
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synthetic genes in the plastids and other required ACC genes in the nucleus [56]. Another 
crucial element not included in the ACC enzyme activity is the biotin protein ligase, 
encoded by birA [25, 66]. This gene encodes the enzyme responsible for the biotin 
ligation to lysine 122 of BCCP.  BCCP is the only destination for biotin in E. coli and this 
post-translational modification is required for activity.  
 
ACC ACTIVITY 
The overall reaction for ACC consists of two parts.  First is the carboxylation of BCCP 
bound biotin in an ATP dependent manner and second is the transfer of this carboxyl 
group from carboxybiotin to acetyl-CoA to generate malonyl-CoA. Biotinylated BCCP is 
the natural substrate although free biotin as well as biotin analogs such as biotin methyl 
ester and biocytin can be used for experimental purposes. These analogs have higher Km 
values than free biotin although still lower than the natural substrate [8]. BC is a part of 
the ATP-grasp superfamily which are proteins containing an ATP binding site known as 
the ATP grasp fold [28]. BC-bound bicarbonate likely initiates the attack of ATP leading 
to a carboxyphosphate which then extracts a proton from biotin leading to enolate biotin.  
Attack by CO2 leads to the formation of carboxybiotin bound to BCCP [16].  The 
carboxybiotin is used as a swinging arm in order to position the carboxybiotin for the 
transfer reaction carried out by CT, this is similar to other prosthetic groups such as lipoic 
acid and pantothenic acid (Fig 1.3). CT has been shown to be a member of the crotonase 
superfamily [7].  In the likely reaction a proton must be removed from acetyl-CoA in 
order to form an enolate anion which is stabilized by the oxyanion hole characteristic of 
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crotonases.  This can then attack CO2 from the carboxybiotin enolate to complete the 
carboxyltransfer reaction. 
 
ACC REGULATION 
The overall picture of ACC regulation is not entirely clear and not without some 
conflicting evidence.  Other bacteria, such as Lactoccocus lactis have all of the ACC 
genes in an operon with the rest of the FAS genes, while Bacilus subtilis has the same 
accBC operon as the others plus a second operon containing the CT alpha and beta genes.  
The separated locations (Fig 1.4) for the E. coli ACC genes as well as the degree of 
stoichiometry required for proper function would seem to make a case for overall 
regulation amongst them, but so far no clear element has been found.   There is a direct 
correlation between overall ACC subunit transcription and the growth rate [22].  As ACC 
performs the first committed step in fatty acid synthesis this makes sense that a growing 
cell would require increased membrane production.  This was discovered through use of 
Northern blot analyses of the transcripts of the four genes of ACC.  Labeled transcripts 
increased and decreased in accordance with growth rate.  Growth rate was modulated by 
carbon source, phosphate limitation, and growth initiation [22].   
 
It was previously believed that ACC activity was regulated by the guanosine alarmones, 
(p)ppGpp which are involved in bacterial stringent response triggered by amino acid 
starvation[72]. This came from early observations that relA mutants failed to attenuate 
fatty acid synthesis which was found to be coordinated in rel+ upon amino acid 
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starvation. The effect of increased levels of (p)ppGpp on fatty acid synthesis and 
exogenous fatty acid incorporation was later confirmed in vivo by Heath and Rock [37]. 
They were able to narrow down the target of (p)ppGpp action to plsB, the 
glycerolphosphate acyl transferase.  PlsB carries out the first step in the incorporation of 
acyl chain products into phospholipids. Overexpression of PlsB concomitant with 
artificially increased levels of (p)ppGpp allowed the strains to be able to overcome the 
inhibition of phospholipid synthesis and accumulation of long chain acyl ACPs 
associated with those high levels. It has been shown that the accumulation of long chain 
acyl-ACPs is inhibitory for the enzymes of fatty acid synthesis, enoyl-ACP reductase and 
β-ketoacyl-ACP synthase III, as well as the ACC enzyme reaction itself [21, 39].  In fact, 
ACC inhibition was shown with acyl chains from 6 to 20 carbons long and specific to the 
endogenous ACP species.  Because either the stringent response or analogous 
overexpression of (p)ppGpp synthase I also causes the same accumulation it was possible 
that the (p)ppGpp interaction was solely through PlsB of phospholipid synthesis.  This 
was elucidated by coupling (p)ppGpp synthase I overexpression with total ACC 
overexpression with an additional thioesterase, TesA [22].  ACC overproduction alone 
was unable to alleviate the stringent response, however the addition of the thioesterase 
effectively decoupled phospholipid synthesis and fatty acid synthesis and thus inhibition 
of fatty acid synthesis was indifferent to (p)ppGpp accumulation whether or not ACC 
was overproduced. Therefore there is no direct physiological relevance to the ACC 
inhibition by (p)ppGpp. 
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Flux analysis revealed that the overproduction of the ACC gene products increased the 
overall rate of fatty acid synthesis. Intracellular malonyl-CoA levels were also found to 
be elevated, indicating that ACC activity is a major rate controlling step in fatty acid 
synthesis [22]. 
 
As BC and BCCP exist in an operon, their expression rates are tied to each other. Tight 
transcriptional regulation of this operon exists and appears to be separate from the CT 
subunits.  Overproduction of these proteins via a plasmid containing the operon showed 
only a mild (2-3 fold) increase in protein production over what would be typically 
expected (>10 fold).  Analysis of the transcripts produced showed similar results 
indicating strong transcriptional regulation.  Replacing the native promoter allowed for 
the predicted protein overproduction [57].  The regulator was determined to be BCCP 
itself. Overexpressing BCCP severely limits growth although expression of the entire 
accBC operon does not [22, 54, 79]. Indeed the accBC operon is very conserved within 
bacterial genomes [43]. Overexpression of BC alone also leads to inhibited growth due to 
the fact that BC essentially competes with BirA, the biotin protein ligase, for apo-BCCP. 
Thus the coordinated expression of BCCP and BC is required [1].  The effects of BCCP 
overexpression were analyzed by transcriptional fusions as well as northern blot analysis 
to show that accBC transcription was down regulated [43].  The upstream untranslated 
region of the operon contains some interesting features including a 98 bp sequence 
containing bent DNA and a small 188 bp open reading frame [54].  Analysis showed no 
direct role in BCCP autoregulation as both promoter replacement and complementation 
with Bacillus subtilis AccB led to insensitivity to high levels of BCCP [43].  
10 
 
 
The only early indication of regulation at the level of CT production was the previously 
mentioned ties to the overall growth rate of the cell. ACC subunits must be available in 
stoichiometric amounts and the CT portion lacking the hard wired expression of the BC 
and BCCP portions has posed a problem.  The most glaring of which is that the specific 
locations of the genes at almost polar opposites of the genome.  Both of these genes, accA 
and accD, fall into complex gene clusters of essential genes which may tie into their 
growth rate regulation although RNA sequencing data suggests that they are 
predominantly transcribed as individual genes [53].  When the crystal structure of the 
bacterial CT subunit was finally solved, a key difference from the mammalian CT 
domain was the zinc finger domain found in the beta subunit of the two bacterial CTs 
analyzed [7]. The ability of CT to bind DNA was tested and the results showed the ability 
of CT to bind DNA in a malonyl-CoA dependent fashion where increasing amounts of 
malonyl-CoA disrupted DNA binding.  This was unlike similar dual function enzymes, 
such as BirA in that the enzymatic function was unable to be separated from the DNA 
binding function. The DNA binding function was shown to act nonspecifically and so 
unlikely to be physiologically relevant to ACC regulation [6]. The nucleic acid binding 
was then tested on RNA to see if CT played a role in translation regulation of the 
individual subunits. Electrophoretic mobility shift assays were performed with various 
lengths of accA and accD mRNAs.  Interestingly, the CT showed preferential binding for 
the entire length of both subunit mRNAs with the untranslated regions of both appearing 
inconsequential to binding. This was unusual in several ways, that the untranslated region 
is generally associated with mRNA regulation, the area of binding was in the coding 
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sequence, and that such a long length (approximately 600 bp) was required for maximum 
binding [24, 62].  Four cysteine residues coordinate the zinc ion in the beta subunit and 
are required to varying degrees for both nucleic acid binding and enzyme catalysis 
(certain single replacements of cysteine residues allowed binding and catalysis) [62].  
Overall, the unusual method of regulation including the requirement for mostly naked 
RNA given the length of transcript required was the impetus for the studies presented in 
Chapter Three. The analysis will determine whether or not this is a viable method of 
regulation in vivo using a variety of plasmid constructs and protein labeling measures. 
 
ACC STRUCTURE AND STOICHIOMETRY 
The multi subunit nature of ACC was evident when it was first purified and found to 
fractionate into separate half reaction activities[3]. The meta-stable complex of bacterial 
ACC has been the subject of much study in regards to its precise structure and 
stoichiometry.  Various technical difficulties included the tendency of full length BCCP 
to aggregate and the dissociation of the complex through most means of purification 
made this all the more difficult [3, 66].  While the crystal structures of all the individual 
subunits have been solved, there is no conclusive crystal structure containing all four 
protein components to determine final stoichiometry.  Most of the BC crystal structures 
show it as homodimer in solution while CT exists as a heterotetramer in solution [7, 16, 
89].  The BCCP structure is a flattened barrel of β strands with the biotinylated lysine 
(K122) protruding from the top of the structure and the N and C termini protruding from 
the bottom.  There is also a structural “thumb” which protrudes from the side which is an 
essential structure for bacterial ACC function as it interacts with biotin in the holo-
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enzyme [18, 81, 86].  There is still discussion on whether or not BCCP exists mostly as a 
dimer or monomer in association with the complex. Complementation studies with 
biotinylation mutants as well as affinity tag pull downs of the BC-BCCP complex 
indicated the dimer form of BCCP, while more recent crystallization studies point toward 
a monomeric form (Fig 1.5) [9, 18].  The first proper study of complex formation in E. 
coli ACC was performed by double purification of the BC-BCCP complex. Rhee and 
Cronan were able to measure the relative amounts of BC and BCCP through purification 
and through 35S-methionine labeling of the purified protein products.  This study showed 
a 2:1 molar ratio of BCCP to BC and since BC exists as a dimer it was likely that there 
are four molecules of BCCP per dimer of BC.  This mirrors the amount of protein 
produced naturally by the accBC operon which produces twice as much BCCP as BC 
[59]. A more recent crystallization study examining the co-crystallization of BC and 
BCCP shows the BC existing as a dimer of homodimers associated with four molecules 
of BCCP [9].  This disagrees with the previous studies in that a 1:1 ratio of BC: BCCP 
was obtained.  This crystallization used N terminal hexahistdine-tagged BCCP, which 
was shown to be mostly in the apo form, to perform a pull down of the BC-BCCP 
complex.  Both proteins were overexpressed in a synthetic operon rather than from the 
natural operon which was shown to generate the proteins in a 2:1 ratio of BCCP: BC 
[59].  Further analyses involving all substrates and possibly the crystal structure of the 
entire ACC complex may be required to finally settle this matter.  
 
The crystal structures of CT confirmed its heterotetrameric nature along with the unique 
zinc finger found on the beta subunit which partially shelters the acetyl-CoA binding site 
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[7]. The two subunits form a “canyon” at the dimer interface where the acetyl-CoA is 
recognized by the beta subunit and biotin is recognized by the alpha subunit, thus 
requiring dimerization for catalytic activity [7, 86]. 
 
The structure of BC was solved as a dimer and has also been crystalized with its various 
substrates [16, 89].A unique feature found in the BC dimer is that each monomer has its 
own active site separated by 25Ǻ from the site of dimerization [16]. Unlike many dimeric 
enzymes the active site is not shared and there appears to be no cooperative behavior, 
suggesting the subunits would not communicate. The investigation into this structural 
phenomena led to the conclusion that each subunit had to be fully active in order for the 
enzyme to be functional.  This was determined through hybrid mutant dimers containing 
either one or two functional active sites. The analysis showed a severe decrease in 
activity in the hybrid mutants containing only one active site versus the expectant 50% 
reduction, indicating that some form of communication is occurring [44]. Subsequent 
studies involving dimer formation mutants of BC indicated that dimerization was not 
essential to enzyme function.  The mutants generated had many thousand-fold increases 
in dissociation constants but only lost single fold levels of activity [77]. The conclusion 
was that BC was not required to be in dimer form in order to be active and may associate 
with other subunits in a freer manner than had been previously suggested. Later 
crystallization studies involving nonproductive ATP analogs showed the binding of only 
one active site of the dimer while in one conformation and the other half remaining 
unbound in a different conformation [65].  This supports the idea of alternating catalytic 
cycles between the two subunits which may help prevent excess ATP hydrolysis.  This 
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monomeric BC activity was interesting but lacked the context of the whole complex and 
possibly the physiological relevance.  This led to the studies detailed in Chapter Two 
concerning the requirement for BC dimerization in ACC. 
 
AIM AND SCOPE 
Acetyl-CoA carboxylase is a critical initiator of fatty acid synthesis and thus membrane 
synthesis.  E. coli ACC is the model for multi subunit ACCs and has been well studied 
yet there are still issues being worked out.  Overall subunit composition and 
stoichiometry have yet to be determined definitively.  Many reaction mechanisms and 
structures are only now becoming understood with higher resolution crystal structures 
and modeling.  Regulation is still an area that needs to be examined as the genomic 
composition presents genetic challenges differing between species. In fact we are 
beginning to see the influence of some global regulators such as the nitrogen sensing PII 
enzymes in addition to overall ties to general growth rate [57, 76]. In plants and bacteria 
ACC has been an especially ripe target for metabolic engineering given the desire for 
useful biofuels and other hydrocarbons.  The multi subunit nature of ACC compared with 
the single polyfunctional nature of mammalian ACC has made it a validated drug target 
for antibiotics [31]. Specifically, the goals of this thesis are: the characterization of the 
requirement for dimerization of BC in vivo, the analysis of a potential method of 
regulation of CT by translational self-repression, and the role of PII protein in bacterial 
ACC regulation. 
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Chapter Two will examine the BC dimerization requirement. Through the use of 
monomeric site directed mutants, the physiological requirement of BC dimers will be 
examined.  This will be done in physiological environments and then analyzed through 
biochemical as well as phenotypic means. 
 
Chapter Three will determine if the proposed method of regulation of the two subunits of 
CT is physiologically relevant. The proposed method of CT regulation was devised from 
the fact that structural analysis showed the AccD subunit to contain a zinc finger domain.  
This domain was able to specifically bind CT alpha and beta transcripts leading to a non-
canonical method of translational control.  A number of questions arose concerning the 
validity of this regulation in vivo.  Therefore in order to test the regulation, a varied 
expression and label monitoring in vivo approach will be taken determine relevance of 
this regulation. 
 
Chapter Four will be a brief introduction and explanation of work done on the PII protein 
GlnB and its ability to regulate ACC activity. This activity was shown in plant plastids 
and so the experiments were replicated with equivalent E. coli proteins.  GlnB was 
purified and tested for its ability to inhibit an ACC enzymatic assay. 
 
Chapter Five will provide a summary of the results attained though experimentation.  The 
conclusions gained will be analyzed for further work to be done in order to resolve 
remaining and newly generated questions surrounding ACC. 
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FIGURES 
 
FIG. 1.1. The Overall Acetyl-CoA Carboxylase (ACC) Reaction. The synthesis of 
malonyl-CoA is carried out in two distinct partial reactions. A. The acetyl-CoA 
carboxylase (ACC) reaction is initiated by the carboxylation of biotin bound to the accB 
encoded biotin carboxylase carrier protein (BCCP) by the accC encoded biotin 
carboxylase (BC). B. In the second partial reaction the carbonyl group is transferred from 
the biotin moiety of the carrier protein to acetyl-CoA by the carboxyltransferase (CT) 
component (encoded by accA and accD) to give malonyl-CoA. 
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FIG. 1.2. The fatty acid synthetic (FAS) cycle. After ACC has produced malonyl-CoA, 
the malonyl group is transferred to an acyl carrier protein (ACP) by FabD to yield 
malonyl-ACP.  The malonyl-ACP is then condensed with acetyl-CoA in the initial 
condensation reaction by FabH to give β-ketoacyl-ACP.  This is then reduced by FabG to 
produce β-hydroxyacl-ACP.  This product is then dehydrated by either FabZ or FabA to 
give an enoyl-ACP.  This is then further reduced by FabI to give the acyl-ACP which is 
two carbon chain lengths longer than the starting acyl-ACP.  Further condensations are 
carried out by FabH, FabB, or FabF depending on carbon chain length and saturation. 
The cycle continues until the desired chain length is reached, generally 16 or 18 carbon 
lengths in E. coli at which time they become phospholipid acyl chains. 
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FIG. 1.3. The translocation of BCCP bound biotin and carboxybiotin. After transfer 
of carboxyl group from free bicarbonate to biotin through the hydrolysis of ATP in the 
BC active site the biotin moiety must translocate via the BCCP to the CT active site.  
Here the carboxyl group is transferred to the acceptor, acetyl-CoA, in order to generate 
malonyl-CoA.  The biotin arm is likely flexible and has a reported swing range of up to 
30 Ǻ, however the reported distance between the BC and CT subunits of other biotin 
carboxylases have all been shown to be over 55Ǻ[70, 86].  This likely indicates that in 
addition to swing the BCCP itself must translocate between subunits.  
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FIG. 1.4. The relative locations of the ACC genes on the E. coli chromosome. accA is 
located at minute 4(208621-209580 bp). accD is located at minute 50 (2431034-2431948 
bp) and in the opposite direction.  accB is located at minute 72(3403458-3403928 bp) and 
immediately downstream is accC (3403939-3405288 bp). 
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FIG. 1.5. Illustrations of the current models of the ACC stoichiometry.  Model I 
shows a dimer of BC subunits each associated with two BCCP subunits to give a 2:1 ratio 
of BC: BCCP. The BC active sites are associated with the BCCP subunits and are 
denoted by a star at opposite ends of the dimer interface.  This complex in turn is 
associated with a heterotetramer of CTα and CTβ.  This model is supported by total 
protein ratios from subunit pull downs, radiolabeling, as well as overall whole cell 
protein profiling [15, 42, 59]. Model II is a crystal structure generated recently of BC 
bound to BCCP. It shows a dimer of dimers of BC (one dimer composed of red and 
yellow subunits and one dimer composed of pink and purple subunits).  There are four 
molecules of BCCP associated with this tetramer, giving a BC: BCCP ratio of 1:1 and in 
contrast with previous studies.  Here the BCCP molecules (shown as green, dark blue, 
light blue and teal) act as molecular clips to hold the two dimers together which may 
explain why this structure was unseen until they were crystalized together (image 
modified from PDB 4HR7) [9].  
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Chapter Two 
DIMERIZATION REQUIREMENT OF BACTERIAL BIOTIN 
CARBOXYLASE IN VIVO 
INTRODUCTION 
The first component in the enzymatic activity of the ACC complex, biotin carboxylase 
(BC), catalyzes the carboxylation of the protein-bound biotin moiety of the subunit biotin 
carboxylase carrier protein (BCCP) with bicarbonate in an ATP-dependent reaction.  As 
previously discussed, BC is found as a dimer in cell extracts and the carboxylase 
activities of the two subunits of the dimer are interdependent.  Biotin carboxylase is 
encoded by accC in a tightly controlled operon with accB, the gene encoding BCCP [54, 
57].  The functional ACC is thought to consist of a dimer of BC subunits in a complex 
with four molecules of BCCP and one α2β2 CT heterotetramer(Fig 1.5) [15]. Interactions 
among the components of the functional complex are weak and upon cell lysis they 
readily dissociate into stable CT and BC components plus a metastable complex of a BC 
dimer with four BCCP molecules.  The subunits can be readily purified in order to study 
the partial reactions and each of the acc genes is essential for growth of E. coli [5]. 
 
Structural studies have demonstrated that each BC monomer contains a complete active 
site and the two active sites of a dimer are separated by 25Å [16, 19, 77]. Thus, the BC 
active site is not comprised of residues from both subunits (i.e. a shared active site) as 
seen in many dimeric enzymes.  Kinetic analyses have shown no cooperative behavior for 
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any of the substrates [19], suggesting that there is no communication between the 
subunits.  So why does BC exist as a dimer?  To answer this question, hybrid BC 
molecules were made where one subunit was wild-type and the other contained an active 
site mutation that caused at least a 100-fold decrease in activity [44].  If the subunits act 
independently, then the activity of the hybrid should be about one-half of the wild-type 
activity.  However, if communication between the subunits is required for activity, then 
the activity would be less than half of wild-type.  The activity of the hybrid enzymes 
ranged from 0.35% to 3.6% of the wild-type activity, indicating intersubunit 
communication [44].  A plausible explanation for the dominant negative effect of the 
mutations is that the two BC subunits cannot catalyze the reaction simultaneously.  
Instead, the two subunits might alternate catalytic reactions, such that while one subunit 
is binding substrate and undergoing catalysis, the other subunit is releasing product [23, 
44].  If one of the subunits contains a mutation that results in a significant decrease in 
catalytic rate, it might also lead to a decrease in the catalytic rate of the wild-type subunit, 
indicating that the catalytic sequences of the subunits are inextricably linked.  This 
scenario has received support from a BC crystal structure in which an ATP analogue is 
found bound to only one of the two subunits of a dimer [65]. 
 
Shen and coworkers [77] subsequently investigated the catalytic activity of mutant biotin 
carboxylase proteins deficient in their ability to form dimers.  They made amino acid 
substitutions in the BC dimer interface which hindered its ability to form dimers to 
varying degrees.  They showed that the activities of the monomeric BC proteins were 
only slightly diminished (about 3-fold) when compared to the dramatic increases in the 
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Kd values for dimer formation (5000 to 8000-fold depending on incubation conditions).  
They concluded that dimer formation may not be required for the catalytic activity of BC 
and that although the proteins likely exists as a dimer in the ACC complex, monomers 
might also interact with the other subunits.  However, these experiments have the caveat 
that none of the other ACC subunits were present and only the first partial reaction was 
assayed.  This raised the possibility that dimerization might be a prerequisite for the 
interaction of BC with the other subunits to form the complex required for the overall 
ACC reaction.    
 
In this Chapter I report in vivo evidence that BC must be in dimer form to allow it to 
fulfill its physiological function.  This was accomplished by recreating the dimer 
interface mutants in a plasmid based complementation system whereby only high levels 
of expression allowed the severe dimer mutants to permit growth while mutants with 
better ability to form dimers as well as wild type permitted growth at far lower levels of 
expression. 
 
MATERIALS AND METHODS 
Media and Culture Conditions 
All strains were grown in LB liquid or solid agar media or M9 liquid media. The M9 
medium contained 0.4% glycerol as carbon source.  Antibiotics were utilized at the 
following concentrations (in µg/mL): kanamycin sulfate 20, sodium ampicillin 100, 
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spectinomycin sulfate 100, and tetracycline hydrochloride 20.  LB medium was used for 
all strain constructions whereas M9 minimal salts medium was used for growth curve 
analysis. Arabinose was added at concentrations between 1.3 M and 13 mM (0.2%) for 
induction of plasmid-based genes. Glucose was added to 0.8% for repression of the 
arabinose promoter. 
 
Plasmid Constructions 
 All strains used in this study were derived from Escherichia coli K-12 strain MG1655.  
Plasmid pACS221 was constructed by inserting the coding sequences of the E. coli 
accBC operon with the native accB ribosome binding site into EcoRI and XbaI digested 
pBAD322K.  The insert was generated by PCR amplification using primer 5’ EcoRI 
accBC Ec-341 plus primer 3’ Xba accBC Ec and MG1655 genomic DNA as template.  
Plasmid pACS199 was constructed by inserting a fragment containing the S. enterica 
LT2 accBC operon (called accBC Se) together with its native promoter into BamHI and 
XbaI digested vector pAH144. The insert was generated using primers 5’ BamHI accBC 
Se-553 and 3’ XbaI accBC Se and S. enterica LT2 genomic DNA as template.  The 
ligation products were transformed into strain WM95 to allow the Pi protein-requiring 
plasmid to replicate. 
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CRIM Plasmid Integration 
 MG1655 was first transformed with CRIM helper plasmid pAH69 which is temperature-
sensitive for replication and encodes intHK022 phage integrase [36].  The cells were then 
grown at 30°C, made electro-competent, transformed with plasmid pACS199, and 
incubated at 42°C for one h to induce expression of intHK022.  Plating on LB agar 
containing spectinomycin at 37° selected for integration of pACS199 which is unable to 
replicate in wild-type E. coli strains. Spectinomycin-resistant transformants were then 
streaked for single colonies and then tested for the presence of single integrants by colony 
PCR using the pool of primers: CRIM HK022 P1, CRIM P2, CRIM P3, and CRIM 
HK022 P4 [36]. A successful single integrant that gave PCR products of 289 and 824 bp 
was called strain AS59.  This strain contains two copies of the accBC operon, the 
endogenous operon plus the S. enterica LT2 copy integrated into the phage attachment 
site (Fig. 2.1). 
 
Construction of the ∆accBC Strain 
A linear DNA fragment was amplified from the template plasmid pKD3 using the 
primers 5’ accBC KO -362 and 3’ accBC KO.  The resulting linear PCR product 
contained a chloramphenicol resistance cassette flanked by FLP recognition target sites 
along with sequences in the primers homologous to the 5’ and 3’ ends of the accBC 
operon.  Strain AS59 was transformed with the λ red recombinase expressing plasmid 
pKD46.  The transformed strain was grown at the temperature permissive for plasmid 
replication (30°C) with arabinose and then made electro-competent.  These cells were 
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transformed with the linear DNA fragment with selection for chloramphenicol resistance 
to replace accBC with the resistance cassette (Fig. 2.1B).  The deletion was verified by 
colony PCR using external primers 5’ accBC Ec check for and 3’ accBC Ec check rev. In 
the resulting construct, strain AS61, the native accBC operon had been replaced with the 
chloramphenicol resistance cassette and cell growth was supported by the ectopic S. 
enterica accBC operon.   
 
accBC Complementation 
Plasmid pACS221 was tested for its ability to complement a ΔaccBC null mutant. Strain 
AS61 was transformed with plasmid pACS221 and grown in LB medium containing 
0.2% arabinose to induce expression of AccB and AccC.  This strain was then transduced 
with a phage P1 lysate grown on strain CAG18466 which contains a Tn10 element 
closely linked to the attHK022, the site at which accBC Se is inserted (Fig. 2.1C).  After 
selection for tetracycline resistance the resulting colonies were screened for sensitivity to 
spectinomycin indicating that the ectopic accBC Se copy had been replaced.  These 
transductants required arabinose-induced accBC expression from plasmid pACS221 for 
robust growth and failed to grow in the presence of glucose which represses basal 
expression from the arabinose promoter.  Strain AS109 was constructed by first inserting 
the attHK022::accBC Se ectopic copy and then the ΔaccBC::cat locus from strain AS61 
into strain AS105 by P1 transduction.  Since plasmid pACS221 provided 
complementation it was transformed into strain AS109 and in the presence of arabinose 
the transformed strain was transduced with P1 phage grown on strain CAG18466. 
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Tetracycline resistant transductants were selected and then screened for spectinomycin 
sensitivity.  The resulting strain, AS110, lacks a chromosomal copy of accBC and 
requires plasmid pACS221 plasmid plus arabinose for rapid growth. 
 
Site Directed Mutagenesis 
Complementary primers (Table 2.2) were designed to anneal to plasmid pACS221 at the 
site of the desired mutations to introduce the R19E, E23R or F363A mutations into AccC.  
These primer pairs were then used to amplify the entire pACS221 plasmid using Pfu 
polymerase.  The resulting products were then digested with DpnI to minimize template 
background and transformed.  The resulting plasmid inserts were then sequenced to 
verify the expected mutational changes. 
 
Growth Measurements 
The desired plasmid and strain combinations were inoculated into LB containing the 
appropriate antibiotics and arabinose and grown overnight.  The strains were then sub-
cultured into M9 minimal medium with 0.4% glycerol as the primary carbon source and 
the appropriate concentrations of kanamycin and arabinose.  These overnight cultures 
were then diluted to an approximate optical density at 600 nm of 0.001 and 300 µL of 
each sample was pipetted into 5 wells of a Bioscreen C plate. The medium was 
supplemented with 1.3 M arabinose, 0.8% glucose, 13 mM (0.2%) arabinose or left 
unsupplemented.   The plates were placed into the Bioscreen C analyzer (Growth Curves 
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USA) and allowed to grow for 48 h with continuous high intensity shaking and 
monitoring every 15 min.  The resulting growth data were averaged and plotted. 
 
Biotin Carboxylase Partial Purification and Assay 
The method of Guchhait et al. [35] was used for the partial purification and assay of wild 
type and mutant BC proteins. Strains requiring plasmid-based BC expression were grown 
in 500 mL of LB medium with kanamycin and 0.2% arabinose until an OD600 of 1.0 was 
reached.  The cultures were then pelleted and stored at -80°. The samples were suspended 
in 20 mL of 100 mM potassium phosphate buffer (pH 7.0) containing 1 mM EDTA and 5 
mM 2-mercaptoethanol. All procedures were performed at 4°C.  The cells were then 
lysed by multiple passages through a French pressure cell.  The lysates were centrifuged 
to remove cell debris and the supernatant fractionated with ammonium sulfate at 4°C.  
The supernatants were stirred while sitting in ice as 144 g per liter (25% of saturation) of 
crushed ammonium sulfate was slowly added.  The mixture was allowed to stir for 15 
minutes on ice and then centrifuged.  The recovered supernatant was then brought to 45% 
of saturation by the addition of 125 g per liter of ammonium sulfate.  The precipitated 
protein was recovered by centrifugation and stored at -80°.  Prior to use the protein 
precipitates were suspended in a minimal volume of buffer, dialyzed for 3 h at 4°C 
against the above phosphate buffer to remove ammonium sulfate, and the protein 
concentrations were then measured by the Bio-Rad Protein assay. 
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The relative activities of the wild type and mutant biotin carboxylases were determined 
by ATP-dependent carboxylation of free biotin with [14C]bicarbonate (American 
Radiolabeled Chemicals) [35, 73].  The reaction mixtures contained 100 mM Tris-HCl 
buffer (pH 8.0); 3 mM ATP; 8 mM MgCl2; 8 mM NaH
14CO3 (1.28 mCi/mmol); 100 mM 
potassium d-biotin; 3 mM glutathione; 10% ethanol; and 250 µg of  partially purified 
biotin carboxylase protein in a volume of 500 µL.  All of the reaction components were 
mixed and the reaction was initiated by addition of enzyme.  After incubation of the 
reactions at 30°C for 15 min, 400 µL of the reaction mixture was removed to a test tube 
containing 1 mL of ice-cold water containing a few drops of octanol (to prevent 
foaming). These tubes were placed in ice and CO2 was bubbled through the solution for 
30 min to remove unincorporated [14C]bicarbonate by exchange with excess CO2 .  After 
thorough gassing 100 µL of 0.1 N NaOH was added to each reaction. The contents were 
transferred to a vial of scintillation fluid and the 14C incorporation was measured.  Note 
that due to exchange of [14C]bicarbonate with CO2 present in the buffers and atmosphere, 
the results are given as counts incorporated rather than molar quantities. 
 
RESULTS 
Construction of an E. coli Strain Dependent on Plasmid-Based BC Expression 
In order to test the effects of the dimer interface mutations in vivo, it was necessary to 
construct a strain in which the sole source of BC were plasmids encoding either the wild 
type or mutant BCs under a controllable promoter.  BC is an essential protein and since it 
was unclear if the mutant BCs would be able to support growth, I used the approach 
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developed for another essential gene, fabH [48].  In this approach a second highly 
homologous copy of the accBC operon, that of Salmonella enterica LT2, was integrated 
into the HK022 phage attachment site of the E. coli genome using the phage integrase 
system developed by Haldiman et al. who produced the strain AS59 [36](Fig. 2.1A.).  I 
then used recombineering to delete the normal chromosomal copy of accBC to obtain a 
strain having only the distal S. enterica accBC operon which was marked with a 
spectinomycin resistance cassette to give strain AS61 (Fig. 2.1B.).  This strain was 
transformed with plasmid pACS221 which expresses the E. coli accBC operon with the 
native accB ribosome binding site but in which the araBAD promoter replaced the native 
promoter.  The resulting transformed strain contained two functional (but non-identical) 
copies of the accBC operon.  I then tested whether or not the S. enterica accBC operon 
could be removed by transduction using a phage lysate grown on strain CAG18466, 
which carries a Tn10 transposon insertion closely linked to the HK022 phage attachment 
site (Fig. 2.1C.).  The resulting tetracycline resistant transductants were then scored for 
spectinomycin sensitivity.  If the plasmid-encoded BC proteins could functionally replace 
the S. enterica protein, then spectinomycin sensitive colonies would result (Fig. 2.1C. 
path 1, Fig. 2.3B.), whereas the opposite result (only spectinomycin-resistant 
transductants), would indicate that the S. enterica gene could not be removed (Fig 2.1C. 
path 2), demonstrating that the gene was unable to provide sufficient BC function for 
growth.  The resulting spectinomycin-sensitive strains contained a single plasmid borne 
accBC operon under arabinose regulation.  Note that although I was testing only BC 
proteins, all constructs also encoded a wild type accB gene.  This is because sole 
overproduction of either of these proteins is growth inhibitory, presumably due to 
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disruption of the stoichiometry of ACC (or of a subcomplex) [1, 43, 45, 57].  The S. 
enterica accBC operon was used because the gene organization and encoded proteins are 
essentially identical to those of E. coli, but the genes differ sufficiently at the nucleotide 
level (mainly due to differing bases in codon wobble positions) that homologous 
recombination is prevented.  Therefore, the mutations of plasmid-borne accC genes could 
not be repaired by recombination with the chromosomal copy.  The accBC expression 
plasmid used was pBAD322K, a medium copy number plasmid with inducible 
expression from the araBAD promoter [17].  Strain AS110, a ΔaraBAD strain blocked in 
arabinose catabolism, was then constructed to allow induction by low arabinose 
concentrations. 
 
Site directed accC alleles of plasmid pACS221 were constructed to introduce the R19E, 
E23R, and F363A residue substitutions implicated in dimerization(Fig.2.3) [77]. Relative 
to the wild type BC, the R19E, E23R, and F363A mutations were reported to increase the 
dimer dissociation constants by approximately 7000 to 8000, 5500 to 6000 and 4 to 28-
fold, respectively [77], with only modest effects on in vitro BC activity [77].  These 
plasmids were introduced into strains having the integrated S. enterica accBC operon as 
the sole source of BC activity.  The ability to remove the ectopic S. enterica accBC 
operon was tested by transduction as above and the transductants were plated on LB agar 
plates containing 13 mM (0.2%) arabinose.  All three strains carrying plasmids that 
encoded a mutant BC protein grew on this medium, indicating that the ectopic S. enterica 
accBC was functionally replaced, even though the colonies were smaller than those 
formed by the strain expressing wild type BC.  Moreover, unlike the strain expressing 
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wild type BC, the strains encoding the R19E and E23R proteins failed to grow in the 
absence of arabinose (Fig. 2.3).   
 
Complementation of the ∆accC Strain by Plasmid-Borne accC Alleles 
The growth rates in liquid media of the all four strains were analyzed in detail using the 
Bioscreen C growth curve analysis system.  The strains encoding the mutant BCs all 
grew under maximal induction conditions, as previously seen by colony 
formation(Fig.2.2A), but the growth curves lagged behind those of the strain carrying the 
wild type plasmid and the wild type strain carrying an empty vector (Fig. 2.4D). Under 
low arabinose conditions (1.3 M) the mutant least defective in dimerization (F363A) 
grew similarly to wild type, whereas the other two strains that encoded BC mutant 
proteins having much higher dissociation constants, grew poorly (Fig. 2.4C). In media 
devoid of arabinose or supplemented with glucose (to repress promoter function), the two 
severely defective dimerization mutants, R19E and E23R, failed to grow, while 
expression of the minimally impaired mutant F363A or wild type enzymes allowed slow 
growth under these low expression conditions (Fig. 2.2, Fig. 2.4A-B).   
 
BC Activities of Cell Extracts 
All of the dimer interface mutant proteins allowed growth when highly expressed 
whereas the R19E and E23R mutants failed to grow at lower expression levels at which 
growth of strains expressing the wild type and F363A proteins proceeded. Shen et al. [77] 
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reported that the catalytic activities of the dimer interface mutant proteins were only 
modestly diminished relative to the loss of their ability to form dimers. In their assays the 
R19E and E23R mutant proteins had Kcat values about 30% that of the wild type enzyme 
compared to a roughly 5500 to 8000-fold increases in Kd, while the F363A mutant 
retained around 90% of the Kcat with a much smaller (4 to 28-fold) increase in Kd.  My 
analyses assumed that the mutant proteins were expressed as efficiently as the wild type 
protein.  If so, we would expect that the ratios of the BC activities in partially purified 
cell extracts would reflect those of the purified proteins studied by Shen et al. [77].  I 
used a more direct assay than the prior workers, the incorporation of [14C] bicarbonate 
into carboxybiotin [35], and found that the R19E mutant extract had about half the 
activity of the wild type protein extract whereas the F363A mutant extract had 
approximately 84% of the wild type activity, values in good agreement with those 
reported by Shen et al. [77].  However, for unknown reasons multiple attempts to 
measure activity of the E23R mutant extracts showed only background activity (data not 
shown).  I had chosen the pBAD322K vector because its range of protein expression 
levels seemed likely to overlap with the level of BC expression in wild type cells and this 
was the case. The extract of a wild type strain had 29% of the activity of a strain 
expressing the fully induced plasmid-borne wild type BC (Fig. 2.5) indicating only 
modest overexpression of BC. I also assayed the uninduced level of expression and found 
it to be 12-fold lower than the fully induced level.  
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DISCUSSION 
My data demonstrate that ACC activity in vivo depends on the ability of BC to efficiently 
form dimers.  It should be noted that proteomic data obtained by three mass spectral 
analyses based on the yield of BC (AccC) peptides [42, 47, 59] or on quantitative 2D gel 
separations [47, 58] give a consistent value of 1477 +/- 150 BC molecules per E. coli cell.  
This translates to an intracellular BC concentration of about 2.4 M, a concentration well 
above the reported Kd (~0.1 M) for dimer dissociation of the wild type BC [77] and 
consistent with its isolation as a stable dimer.  In my experiments, basal expression of 
accBC from the plasmid constructs (Fig. 2.5) give BC levels about one-fourth that of wild 
type cells and thus the intracellular BC concentration would be roughly 0.6 M whereas 
the Kd values of the R19E and E23R mutant proteins (703-843 and 540-600 M, 
respectively) are hundreds fold higher [77].  Thus, if the Kd values obtained in vitro 
reflect the in vivo situation, it would be expected that strains producing R19E and E23R 
proteins would be unable to grow at basal levels of expression whereas strains expressing 
the wild type protein or the more modestly defective F363A mutant protein (Kd values of 
4 to 28 M) might grow slowly in the absence of induction.  These expectations were 
indeed fulfilled (Fig. 2.4).  The increased intracellular BC concentration resulting from 
induction of accBC expression allowed growth of strains expressing the R19E and E23R 
proteins and increased inducer concentration resulted in more rapid growth. These are the 
results expected if higher intracellular BC concentrations can partially overcome the 
dimerization defects of the mutant proteins.  Indeed, the E23R protein is not completely 
defective in dimer formation because it formed dimers at 300 M, the concentration used 
for its crystallization (the R19E protein failed to crystallize) [77].  Finally, the subtle 
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dimerization defect of the F363A protein was seen when glucose was used to repress 
basal expression of the ara pBAD promoter (Fig. 2.4B).   
 
Although the in vivo results are consistent with the in vitro data, it may be too much to 
expect strict quantitative agreement.  This is because it is unclear what fraction of BC 
subunits must be present as dimers to allow growth and whether or not the presence of 
the other ACC subunits aids BC dimerization.  Moreover, the presence or absence of 
substrates gave large changes (up to 6-fold) in the Kd values obtained in vitro for the 
mutant proteins [77] which introduces additional uncertainties. 
 
Further corroboration of the dimerization requirement comes from studies performed on 
pyruvate carboxylase (PC) from Staphylococcus aureus [92].  This PC contains a BC 
domain organized very similarly to that of E. coli. The equivalent dimerization deficient 
mutants were created in the BC domain and assayed for dimerization and activity. These 
mutants assembled into their full tetrameric form, however they lacked BC activity.  
Furthermore, the BC domains themselves were isolated and the wild type SAPC BC 
domain was found to be both monomeric and inactive. This concluded that proper dimer 
formation of BC was required even within the fully assembled SAPC tetramer. 
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TABLES AND FIGURES 
 
Table 2.1. Bacterial strains and plasmids 
Strain Relevant characteristics Source 
MG1655 Wild type Lab collection 
AS59 MG1655, attHK022::accBC Se  aadA This work 
AS61 AS59, ΔaccBC::cat  This work 
AS105 MG1655, ΔlacZY ΔaraBAD This work 
AS109 AS105, ΔaccBC::cat attHK022::accBC Se  aadA This work 
AS110 AS109, zcc-282::Tn10/ pACS221 This work 
CAG18466 MG1655, zcc-282::Tn10 [78] 
WM95 pir+ cloning strain [63] 
Plasmids   
pBAD322K Expression vector, Kanr [17] 
pACS199 pAH144 containing S. enterica accBC  This work 
pACS221 pBAD322K encoding wild type E. coli  AccB and AccC  This work 
pACS222 pACS221 encoding AccB and AccC R19E This work 
pACS223 pACS221 encoding AccB and AccC E23R  This work 
pACS224 pACS221 encoding AccB and AccC F363A  This work 
pAH69 IntHK022 integrase expression plasmid [36] 
pAH144 pir dependent attPHK022 integration plasmid, Spcr Strr [36] 
pKD3 Chloramphenicol cassette plasmid [20] 
pKD46 λred recombinase expression plasmid [20] 
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Table 2.2. PCR Primers 
Primer Sequence (5’-3’) 
5’ BamHI accBC Se 
-553 
ggatcctggcaaacactgcataacgtcgtc 
3’ XbaI accBC Se tctagaaagcgggaattgtacatg 
5’ EcoRI accBC Ec 
-341  
cggggaattcgctttacagacgg 
3’ Xba accBC Ec tctagaaagcggggattgtacctta 
5’ accBC KO -362 cggtgttgaaggttatttacatgttagctgttgattatcttcccttgtgtaggctggagctgcttcga 
3’ accBC KO cggccttttgacgctttagcagtcttatttttcctgaagaccgagcatatgaatatcctccttag 
5’ accBC Ec check 
for 
tctatcttgtcgcgatcctggcat 
3’ accBC Ec check 
rev 
taagcggctactaaccaaactgcc 
CRIM HK022 P1 ggaatcaatgcctgagtg 
CRIM HK022 P4 ggcatcaacagcacattc 
CRIM P2 acttaacggctgacatgg 
CRIM P3 acgagtatcgagatggca 
accC R19E SDM gattgcattgcgtattcttgaagcctgtaaagaactggg 
accC R19E SDM 
RC 
cccagttctttacaggcttcaagaatacgcaatgcaatc 
accC E23R SDM cgtgcctgtaaacgactgggcatcaagac 
accC E23R SDM 
RC 
gtcttgatgcccagtcgtttacaggcacg 
accC F363A SDM cacctggcggtgctggcgtacgtt 
accC F363A SDM 
RC 
caacgtacgccagcaccgccaggtg 
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FIG. 2.1. Construction of the plasmid-complemented accBC deletion strain and the 
test for BC function.
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FIG. 2.1. (cont.) A. Plasmid pACS199 was transformed into a wild type strain carrying 
the integrase expression plasmid pAH69.  Plasmid pACS199 contains the entire S. 
enterica LT2 accBC operon with its native promoter plus the attP HK022 integration site.  
This allows for the integration of the plasmid into the attB HK022 site of the E. coli 
chromosome. B. Using red catalyzed site-specific recombination, a PCR product 
containing a chloramphenicol resistance cassette (cat) flanked by sequences homologous 
to the endogenous accBC operon was inserted into the chromosome replacing the native 
sequence.  After selection for chloramphenicol resistance the resulting strain, AS61, 
contained only the ectopic S. enterica accBC operon.  C. Plasmid pACS221 which 
contains the E. coli accBC operon under arabinose promoter control was then introduced 
into the strain.  The transformed strain was then transduced with a phage P1 lysate grown 
on strain CAG18466 which contains a tetracycline resistant Tn10 linked to the attB 
HK022 site.   In this depiction of the genetic cross a crossover to the right of the Tn10 is 
required.  The second crossover needed for tetracycline resistance can occur either within 
the interval between the Tn10 and the ectopic accBC operon or to the left of the aadA 
gene. Tetracycline resistant transductants were selected and screened for streptomycin 
sensitivity. If crossover path 1 is taken, then the transductants would be spectinomycin 
sensitive indicating that the plasmid copy allows growth and that the resulting strain is 
dependent on plasmid based accBC expression for viablity.  If crossover path 2 occurs, 
all transductants would retain spectinomycin resistance and the ectopic S. enterica copy 
linked to aadA indicating that the plasmid borne accBC construct was unable to provide 
sufficient expression for growth.   
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FIG. 2.2. Complementation of BC with mutant plasmids. A. Complementation of an 
ΔaccBC deletion strain by wild type and mutant plasmid based accBC is shown by 
growth on LB with high amounts of arabinose.  B. The successful removal of the ectopic  
S. enterica copy of accBC by P1 transduction is shown by tetracycline resistance and 
spectinomycin sensitivity under high arabinose conditions. C. Under conditions of 
glucose repression little to no visible growth is seen on plates. 
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FIG. 2.3. BC dimer interface mutants. Site directed mutants were created at the BC 
dimer interface which made BC monomeric in solution.  Residue substitutions R19E 
(red), E23R (green), and F363A  (yellow) gave increased Kd values of 8700, 5500, and 
40 fold respectively.  The BC dimer contains 2 active sites (red star) which are located 
25Å away from the dimer interface. (Modified from PDB 1DV1[85]) 
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FIG. 2.4. Growth of strains dependent on plasmid-encoded mutant BC proteins. 
Derivatives of the accBC deletion strain (AS109), cured of the S. enterica LT2 accBC 
operon by transduction, that contained plasmids encoding accB plus one of the accC 
alleles were grown in M9 minimal medium in a Bioscreen C analyzer with 0.4% glycerol 
as the primary carbon source and supplementation with either arabinose or glucose as 
given.  The plasmids encoding the dimerization deficient BC mutant proteins R19E and 
E23R were unable to allow growth (complement) at low levels of expression. A. Shows 
growth of the strains in the absence of supplementation with arabinose or glucose. B. 
Shows the strains grown with the addition of 0.8% glucose to repress expression from the 
araBAD promoter. C. Shows the strains grown with 1.3 M arabinose in addition to 
glycerol to give a low level of induction.  D. Shows the strains grown with the addition of 
13 mM (0.2%) arabinose for maximum induction.  The measurements were averages of 
at least 3 independent repetitions with 5 duplicates per repetition. 
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FIG. 2.5.  Relative BC activities of partially purified cell extracts. Biotin carboxylase 
preparations of the various strains shown were partially purified from cell extracts as 
described in the Material and Methods section.  Partially purified protein (250 µg) was 
incubated with 100 mM biotin, 3 mM ATP, and 8 mM [14C]bicarbonate.  The reactions 
were incubated at 30° for 15 min and the reactions were terminated by the addition of ice 
cold water. CO2 was then bubbled through the samples for 30 min on ice to eliminate 
residual [14C]bicarbonate and the gassed samples were then transferred to scintillation 
counter vials for counting.  The control experiments were performed in exactly the same 
manner except that biotin was omitted. All background values were essentially identical 
to that of the protein extract of the wild type strain and for simplicity only that control is 
given.  The activity of the wild type strain MG1655 protein extract was included to allow 
comparison with the activities given by plasmid based expression. 
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Chapter Three 
EVIDENCE AGAINST TRANSLATIONAL REPRESSION BY THE 
CARBOXYLTRANSFERASE COMPONENT OF ESCHERICHIA 
COLI ACETYL-COA CARBOXYLASE 
INTRODUCTION 
The second component of the ACC complex is the carboxyl transferase (CT) subunit.  In 
this partial reaction of ACC, the biotin-bound carboxyl group is transferred to acetyl-CoA 
to form malonyl-CoA (Fig. 1.1).  The transfer reaction is catalyzed by a heterotetrameric 
complex of two additional subunits, AccA and AccD [7, 35, 54].    In numerous bacteria 
the four acc genes are found in an operon together along with other fatty acid synthetic 
enzyme genes.  This simplifies stoichiometric production of the ACC subunits and allows 
for more direct correlation with fatty acid synthesis. However, in E. coli only the accB 
and accC genes are cotranscribed, accB being the upstream gene [54] and consistent with 
the production of AccB in a 2:1 molar ratio to AccC as measured by several different 
assays [15, 42, 47, 59].  In contrast, the loci of the accA and accD genes are distant from 
the accBC operon and from one another (Fig 1.4).  This raises the questions of how 
stoichiometric production of AccA and AccD is achieved to form a heterotetrameric CT 
complex.  Proteomic analyses of E. coli and its very close relative, Shigella flexneri, 
indicate that equimolar amounts of AccA, AccC, and AccD are made and that the levels 
of AccB are twice that of AccC [42, 47, 59].  The AccA and AccD subunits are 
consistently isolated from cell extracts as the AccA2-AccD2 heterotetramer [7, 35, 54] and 
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proteomic analyses indicate that neither subunit exists in excess [42, 47, 59]. A more 
recent total ribosome profiling study indicates that the two subunits are not only present 
at equimolar levels, but are synthesized at similar rates [51].   
  
In 2010, Meades and coworkers [62] reported that the AccA-AccD stoichiometry is 
determined by a translational repression mechanism in which the CT heterotetramer 
binds the coding regions of the accA and accD mRNAs and thereby inhibits production 
of the CT subunits.  The CT-mRNA interactions were reported to be mediated by a zinc-
finger structure present on the AccD subunit.  Although this model has attractive aspects, 
it is based solely on in vitro results and stipulates that 500-600 nucleotide long stretches 
of the accA and accD mRNA molecules must be available for tight binding by the CT 
tetramer [62]. However, if this were the case, these would be most atypical E. coli mRNA 
molecules because in bacteria, nascent mRNAs synthesized by RNA polymerase 
immediately become substrates for the translation apparatus [34, 82].  Numerous lines of 
evidence (e.g., transcriptional attenuation and polarity in operons) demonstrate that 
ribosomes are loaded onto nascent mRNAs as soon as the ribosome binding site and the 
first few codons have been transcribed.  Recently this process, generally called 
transcriptional–translational coupling, has been characterized in remarkable detail by 
ribosome profiling [51, 52, 59].  As RNA polymerase transcribes down the template, the 
chain of mRNA-bound ribosomes grows to form a polyribosome (polysome) until an in-
frame termination codon releases the ribosomes [64, 69].  It has also recently been 
reported that the rate of translation directly determines the rate of transcription due to the 
trailing ribosomes which prevent backtracking by RNA polymerase [74, 75].  In addition, 
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proteins have been identified that interact with both ribosomes and RNA polymerase and 
are believed to coordinate and perhaps bridge the two complexes [11, 12, 26, 74, 75].  
Finally, E. coli has an efficient mechanism to abort elongation of mRNAs that are not 
translated, lest they form RNA-DNA hybrids (R-loops), which block DNA replication 
[49].  The essential termination factor Rho binds to mRNA molecules that are not 
protected by ribosomes and disrupts the RNA polymerase-DNA template complex by a 
5’-3’ procession mechanism that is responsible for polarity in operons [71, 75].  Rho 
protein requires only about 80 nucleotides of unprotected mRNA to bind and actively 
translocate down the mRNA towards RNA polymerase [46].  The stretch of RNA 
required for Rho binding is much smaller than that required for binding the CT tetramer 
in vitro [62] and thus Rho action would be expected to preclude CT binding.  In the 
specific case of the accA and accD transcripts, ribosome profiling detected ribosome 
protected fragments of both messages [51].  The two mRNAs are made at essentially 
identical levels [51, 59] and are translated at very similar efficiencies [51]. Therefore, 
multiple lines of evidence argued that the long stretches of mRNA needed for binding of 
the CT tetramer [62] were unlikely to exist in vivo.  These considerations led me to 
reexamine the question of accA-accD translational repression by in vivo experiments.  I 
utilized a multi plasmid system which exploits the differences between E.coli and T7 
polymerases to allow for the selective induction of CT tetramer overexpression and the 
subsequent monitoring of its effects on translation of accA or accD single subunits.  In 
this chapter I report that in vivo experimental evidence shows that increased levels of CT 
tetramer have no effect on the translation of CT subunit mRNAs. 
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MATERIALS AND METHODS 
Purification of CT Tetramers 
Strains containing the synthetic mini operon plasmid were grown in LB medium 
containing kanamycin. Overnight cultures grown in the same medium were used to 
inoculate 150 mL cultures.  The cultures were grown at 37° C until an OD600 of 0.4 was 
reached.  At this point isopropylthio-β-D-galactoside (IPTG) was added to a final 
concentration of 0.5 mM and the flasks were shifted to 25° C and allowed to express for 
approximately 4 h.  The cells were harvested and the cell pellet of each culture was split 
and frozen at -80° C.  The CT was purified by methods similar to those of Blanchard and 
Waldrop [8] but with minor modifications of some buffers.  The cell pellets were 
suspended in a lysis buffer of 20 mM Tris-HCl (pH 8.0), 500 mM NaCl, and 50 mM 
imidazole to make a 25-fold concentrated cell lysate. Lysozyme was added to 1 mg/mL 
and DNAse I was added to 10 µg/mL.  The cell suspensions were then incubated on ice 
for 1 h. The cells were lysed by freeze thaw treatment. The cells were frozen in a dry ice-
ethanol bath for 3 min and then thawed in a 20° C water bath for 3 min for a total of three 
cycles.  The lysates were then centrifuged for 30 min at maximum speed in a 
microcentrifuge to separate soluble protein from insoluble cellular material.  Qiagen Ni-
NTA slurry was then added to the cleared lysate and the mixture was placed on a roller 
drum at 4° C overnight to allow protein binding. The mixture was then loaded on to a 
mini spin column and centrifuged and the column flow-through collected.  The column 
was washed with three column volumes of wash buffer containing 50 mM KH2PO4 (pH 
7.0), 300 mM NaCl, and 60 mM imidazole. The protein was eluted from the column by 
four washes with an elution buffer containing: 20 mM Tris-HCl (pH 8.0), 500 mM NaCl, 
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and 250 mM imidazole. The eluted protein was then dialyzed against 135 mM KCl, 1 
mM Na2EDTA, 10 mM KH2PO4, (pH 7.0) and subsequently against 500 mM KCl, 10 
mM 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid (HEPES) (pH 7.0).  The 
purified protein was then concentrated using an Amicon Ultra centrifugal filter unit. 
 
CT Activity Assays 
The CT activity of purified proteins was assayed by measuring NADH production 
spectrophotometrically in the reverse of the physiological reaction according to the 
method of Guchait et al. [35].  The reaction mixture contained: 100 mM Tris-HCl (pH 
8.0), 0.1 mM malonyl-CoA, 10 mM L-malic acid, 0.5 mM NAD+, 0.6 mg bovine serum 
albumin, 4.16 units/mL malic dehydrogenase, 7.0 units/mL of citrate synthase, 10 mM D-
biotin methyl ester and carboxyltransferase in a volume of 0.5 mL.  The reaction was 
initiated by addition of biotin methyl ester as carboxyl acceptor.  NADH formation was 
measured at 340 nM on a Beckman DU800 spectrophotometer for 4 min.  Biotin methyl 
ester was synthesized from D-biotin. Dry methanol (13.33 mL) was placed in a round 
bottom flask on ice and 66 μL of acetyl chloride was slowly added to generate 
approximately 3% HCl in methanol. D-Biotin (1.0 g) was added and the mixture was 
allowed to stir overnight followed by rotary evaporation. The biotin methyl ester was 
then precipitated and subsequently dissolved in 40% ethanol. 
 
Overall activities of strains containing the CT overproduction plasmids were compared 
with the wild type strain through use of partially purified extracts.  These extracts were 
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assayed using the 14C carboxyl transfer CT method of Guchait et al. [35].  The strains 
were grown at 37° in 500 mL of minimal medium E containing 0.4% glucose, 0.1% 
Casamino Acids, 0.002% uracil and antibiotic when needed for plasmid maintenance.  
The cultures were grown to OD of 0.4 at which time IPTG was added to a final 
concentration of 0.1 mM and the cultures continued growth for 30 min.  The cells were 
then pelleted and stored at -80° C.  The samples were suspended in 20 mL of 100 mM 
potassium phosphate buffer (pH 7.0) containing 1 mM EDTA and 5 mM 2-
mercaptoethanol. The cells were lysed by freeze-thaw and the cellular debris removed as 
above.  The cell lysate supernatant was then fractionated with ammonium sulfate while 
stirred on ice.  Ammonium sulfate (144 g/L) was slowly added to the supernatant to bring 
the solution to 25% of saturation.  The precipitated protein was removed by 
centrifugation and saved for analysis while the supernatant was brought to 45% saturation 
by the addition of 125 g/L of ammonium sulfate.  The precipitated protein was removed 
by centrifugation and stored at -80°C. The 25-45% ammonium sulfate protein precipitate 
was suspended in buffer and dialyzed similarly to the purified CT complex. The activity 
of the partially purified extracts was assayed in the reverse of the physiological reaction 
by determination of acid-stable 14C carboxyl group transfer from malonyl-CoA to biotin 
methyl ester.  The enzymatic activity is determined by the loss of acid stable radioactivity 
in the presence of biotin methyl ester. The reaction mixture contained: 50 mM Tris pH 
8.0, 100 µM 14C malonyl-CoA, 10 mM D-biotin methyl ester, 6 mg/mL bovine serum 
albumin, and up to 1 milliunit enzyme. The reaction was carried out in a volume of 0.5 
mL and initiated by addition of enzyme. Reactions lacking biotin methyl ester served as 
controls. The reaction was incubated at 30° C and 0.1 mL was withdrawn at 0, 5, 10, 15, 
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and 20 min.  The samples were transferred to a tube containing equal volume of 6 N HCL 
to stop the reaction and release labile 14C compounds.  The tubes were dried at 90° C and 
then transferred to a scintillation vial where scintillation fluid was added and the amount 
of acid-stable 14C was measured. The activity was determined by loss of acid stable 
radioactivity over time, any loss seen in the biotin free control reaction was subtracted. 
 
Plasmid Constructions 
Plasmids pACS229 and pACS230 which express accA and accD respectively from a T7 
promoter were constructed by PCR amplification of the individual genes from genomic 
DNA using primers 5’ accA NdeI, 3’ accA + HindIII, 5’ accD NdeI, and 3’ accD + 
HindIII.  The PCR product generated gave a 5’ NdeI site overlapping the initiation codon 
and a 3’ HindIII site located approximately 90 additional bp downstream of the coding 
sequence. The Pfu polymerase-amplified PCR products were inserted into the NdeI and 
HindIII sites of pVIET to generate plasmids pACS229 and pACS230. These plasmids 
were further modified to remove the lacO element yielding plasmids pACS243 and 
pACS245.  Each plasmid construct was digested with XbaI and SgrAI.  Because the XbaI 
site was blocked by Dam methylation the plasmids were purified from the dam strain, 
ER2925 [90].   Due to the significant SgrAI star activity the plasmids were digested only 
briefly. The oligonucleotides T7 noLacO top and T7 no lacO bottom were annealed 
together by heating at 95 ºC in New England Biolabs T4 ligase buffer and slowly cooling 
to room temperature.  The annealed double stranded oligonucleotide was then gel 
purified and ligated to the XbaI-SgrAI digests to give pACS243 and pACS245.  The 
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resulting constructs contained each acc gene expressed from its own T7 promoter without 
additional regulation by the LacI encoded by the overexpression plasmids. Various 
carboxyltransferase mini operons were constructed and the best was found to be pQE80-
L-Kan as the vector and with accD followed by accA. The two genes were amplified 
using primers 5’ Bam accA plus 3’ SpHI accA and 5’ Bam accD plus 3’ SpHI accD.  The 
products were then ligated to BamHI plus SphI-digested pQE80KL to generate pACS251 
(accA) and pACS254 (accD).  The 5’ SphI RBS accA/accD pQE80 primer along with 
either the 3’ SacI accA or 3’ SacI accD primers were used to amplify either accA or accD 
using the previously generated pACS251 or pACS254 constructs as templates.  The 5’ 
SphI RBS accA/accD pQE80 primer contains a ribosome binding site for the second gene 
of the mini operon. The accA and accD PCR products generated from these primers were 
then ligated into the SphI and SacI sites of the pACS251 and pACS254 plasmids to 
generate pACS263 and pACS262, respectively. To test the effects of tag location, a C-
terminal hexahistidine-tagged version of accD was made in the mini operon.  The primers 
5’ accD ScaI C HIS and 3’ accD ScaI C His were used to amplify the accD sequence.  To 
prevent the N terminal His tag coding sequence from being used at a template while 
preserving the spacing, a BamHI to SphI digested fragment of pACS262 containing accD 
was used as template.  The resulting PCR product contained ScaI sites at either end and 
was digested with that enzyme and gel purified.  The pACS262 construct was digested 
with EcoRI and SphI. The large fragment was gel purified and then blunt ended using T4 
DNA polymerase and the four deoxynucleotide triphosphates. The ScaI digested PCR 
product and the blunted vector were then ligated to give pACS275. 
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To allow greater plasmid compatibility, the promoter free chloramphenicol resistance 
sequence present in the backbone of the pQE80KL constructs was eliminated by 
digestion with NcoI and NheI.  The digest reactions were heat inactivated and the sticky 
ends were filled to blunt ends using T4 polymerase.  The reaction contained the digested 
plasmid as well as 10 mM dNTPs and T4 polymerase.  The reaction was incubated at 12° 
C for 15 min and then heat inactivated by the addition of EDTA followed by heating at 
80° C for 20 min.  The large fragments of the digested and blunted plasmids were then 
gel purified.  After purification the plasmids were self-ligated to generate plasmid 
pACS280 lacking the chloramphenicol resistance gene. Plasmid pACS285 was generated 
similarly but from pQE80-K-L to serve as a vector control. Plasmid pACS281 was 
generated by site directed mutagenesis using the QuickChange PCR protocol (Stratagene) 
on the plasmid pACS280.  The primers C27/30A 5 and C27/30A 3 were used to 
introduce the cysteine to alanine substitution mutations at accD residues 27 and 30. The 
PCR products were then treated with DpnI to digest template DNA and transformed into 
competent cells.  The introduced mutations were verified by sequencing. 
 
Overexpression of CT and Radioactive Labeling of Translation Products 
The labeling protocol was modified from published protocols [84] [83].  The strains 
containing various plasmid combinations were first grown overnight in minimal E 
medium [88] containing 0.4% glucose, 0.1% Casamino Acids and 0.002% uracil.  For 
labeling these strains were then sub-cultured into minimal E medium containing 0.4% 
glucose, 0.002% uracil and supplemented with 5% of an 18 amino acid mixture (0.1% of 
all amino acids excluding methionine and cysteine).  The medium was also supplemented 
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with the antibiotics sodium ampicillin (100 µg/mL), kanamycin sulfate (20 µg/mL), and 
chloramphenicol (50 µg/mL). The cultures were grown to an optical density of 0.4.  Each 
culture was then split in half and IPTG (0.1 mM) was added to one of the two cultures to 
induce CT tetramer overproduction.  Both cultures were allowed to grow for 
approximately 30 min at 37°C to allow for the expression of the accD-accA mini operon 
in the IPTG supplemented culture. After this interval the cells were harvested by 
centrifugation, washed twice with and resuspended in the same medium minus IPTG. 
After 30 min of additional growth at 37°C, rifampicin (200 µg/mL) was added and the 
cultures were incubated an additional 30 min at 37°C to block host RNA polymerase 
activity [83, 84].  The newly synthesized proteins specifically encoded by the T7 
polymerase transcribed mRNA were then labeled by removing 0.2 mL of each culture to 
a separate tube containing 4 µL of 1 mCi/mL 35S-methionine (1175 Ci/mmol). The 35S-
methionine labeling tube was transferred to a 30°C water bath for 5 min and the labeling 
reaction was stopped by placing the tube on ice.  After 10 min on ice the labeled cells 
were harvested in a microcentrifuge and the radioactive supernatant discarded.  The 
labeled cell pellets were suspended in 100 µL SDS cracking buffer (60 mM Tris-HCl (pH 
6.8), 10% glycerol, .01% bromophenol blue, 1% SDS, 1% 2-mercaptoethanol) and the 
proteins denatured at 100°C for 5 min before loading onto a polyacrylamide SDS 
polyacrylamide gel electrophoresis (PAGE) gel. The labeled protein bands were then 
quantitated by phosphorimaging of the dried gel and quantitated using Fujifilm Image 
gauge data analysis software. At the time of radioactive labeling, optical density of the 
remaining culture was measured for normalization and the cell pellets were saved for 
western blot analysis. 
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Western Blotting 
The non-radioactive portion of the cultures were used for analysis and samples were run 
in parallel to the 35S-labeled samples.  The proteins were separated on a SDS-PAGE gel 
and then transferred to an Immobilon PVDF membrane (Millipore).  The gel along with 
blotting filter paper were cut to size and incubated in blotting buffer (250 mM Tris base, 
192 mM glycine and 20% methanol at pH 7.5).  The PVDF membrane was soaked in 
methanol briefly for activation.  The membrane and gel were sandwiched together with 
the blotting filter paper and transferred using a semi-dry transfer apparatus (20 volts for 
30 min). After transfer the membrane was washed in TTBS (10 mM Tris base, 0.09% 
NaCl, and 0.1% Tween 20 at pH 7.5).  The membrane was then blocked in TTBS 
containing 5% dry milk with shaking at room temperature for 1 h. The blocking buffer 
was discarded and the membrane was incubated with primary anti-hexahistidine mouse 
antibody (GE Healthcare) diluted 1:3000 in blocking buffer for 1 h at room temperature 
with orbital shaking.  After incubation the membrane was rinsed once with TTBS and 
then 3 times with orbital shaking for 10 min each.  Anti-mouse IgG horseradish 
peroxidase linked secondary antibody (GE Healthcare) was then incubated with the 
membrane in a 1:10000 dilution in blocking buffer for 1 h at room temperature with 
orbital shaking.  The membrane was then quickly rinsed once as before and then 3 
additional times for 10 min each.  Supersignal West Femto (Thermo Scientific) substrate 
was then added to the membrane and incubated for 5 min.  The membrane was then 
imaged and quantitated using a BioRad Chemidoc instrument with its accompanying 
software. 
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RESULTS 
Experimental Design 
The complexities of testing the effects of a translation product on the translation of its 
encoding mRNA in vivo required an experimental system in which the CT tetramer 
production could be distinguished from translation of the target mRNAs. The separation 
was achieved by the use of two RNA polymerases having different properties in the 
presence of the antibiotic, rifampicin (Fig. 3.1).  Note that more straightforward 
approaches were precluded by the fact that accA and accD genes are essential for growth 
of E. coli [5] and thus cells lacking CT cannot be obtained. E. coli RNA polymerase was 
used for overproduction of CT tetramers whereas phage T7 RNA polymerase was used to 
produce the mRNAs targeted by the putative translational repression mechanism.  The 
two RNA polymerases differ in their response to rifampicin and in the ability of T7 
polymerase to specifically recognize the T7 promoter. This antibiotic inactivates E. coli 
RNA polymerase whereas T7 RNA polymerase is unaffected [14, 83, 84]. Therefore, 
following accumulation of the CT tetramers and T7 RNA polymerase, further synthesis 
of these proteins could be blocked by rifampicin addition.  In contrast the T7 RNA 
polymerase accumulated prior to rifampicin addition would continue to produce the 
mRNAs that are the putative targets of translational repression. Labeling with 35S-
methionine would specifically monitor translation of these mRNA molecules.  
 
The system of three compatible plasmids (Fig. 3.1, Materials and Methods) allowed me 
to produce either the accA or accD mRNAs from the T7 promoter in the presence of high 
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or low levels of the AccA2-AccD2 CT tetramer and specifically monitor translation of 
these mRNAs.    Therefore, following rifampicin dosing and subsequent addition of 35S-
methionione, the only radioactive translation products formed were those encoded by the 
mRNAs produced by T7 RNA polymerase.  In these experiments the very low copy 
number (~5) pVIET T7 expression vector [41] was used and either accA or accD was 
placed downstream of the T7 polymerase promoter and ribosome binding site of the 
vector.  These constructs included a large segment of DNA downstream of the acc gene 
coding sequence to ensure that the normal mRNA species would be available for 
regulation.  The vectors were modified to remove the lacO element of the promoter in 
order to avoid the complication of having two different IPTG-controlled promoters.  T7 
RNA polymerase was expressed from an arabinose promoter on a third compatible 
plasmid, pTARA [91].  The pTARA promoter function was fully repressed by the 
presence of glucose (and absence of arabinose) in order to minimize the amount of T7 
polymerase present. These growth conditions plus the low copy number of the T7 
promoter vector were intended to keep the accA or accD mRNA levels low in order to 
allow sensitive detection of translational repression by CT.  
 
CT Overexpression 
A synthetic accD-accA mini-operon plasmid was constructed (pACS280) to express CT 
from the powerful phage T5 promoter [10].  This promoter is recognized by E. coli RNA 
polymerase but not by phage T7 RNA polymerase and is controlled by a pair of lacO 
operator sequences (the plasmid also encoded the LacI repressor). The mini-operon was 
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constructed such that both proteins carry a hexahistidine tag.  AccD was C-terminally 
tagged whereas AccA was N-terminally tagged, a tag configuration that gave the 
maximal CT activity (Fig 3.2).  Upon induction of the mini-operon with IPTG, a large 
increase in CT expression was seen as determined by western blotting using an antibody 
against the hexahistidine tags of the CT subunits (Fig. 3.3). The samples analyzed were 
the portions of the cultures that had not been labeled with 35S-methionine (see below). 
For western blotting the nonradioactive samples were normalized by culture turbidity and 
the proteins separated by SDS PAGE.  The protein bands were transferred from the gels 
to a PVDF membrane and processed by western blotting with an anti-hexahistidine 
antibody (Fig. 3.3ABC).  Purified AccA was used for controls and quantitation standards 
(Fig. 3.3ABC). For the 35S-methionine labeling the strains also carried a plasmid 
encoding either hexahistidine-tagged AccA (pACS243) or AccD (pACS245) under T7 
polymerase control.  Basal expression from the T7 promoter gave a band visible in 
cultures lacking IPTG (e.g. Fig. 3.3A, lower, lanes 5, 8).  However, these proteins should 
not contribute to the CT levels due to the lack of the other subunit and the presence of 
these bands indicates that AccA and AccD are stable over this time interval when 
expressed alone.  The IPTG-induced cultures showed 7-27 fold increases in tetramer 
expression from the phage T5 promoter plasmid relative to the uninduced cultures based 
on quantitation of the blot intensities (these are minimum overexpression levels based on 
the T7 expressed single subunits of the uninduced samples due to the uninduced tetramer 
components being below levels detectable by western blotting).  The western blotting 
results were confirmed both by the relative amounts of hexahistidine tagged CT 
recovered from induced and uninduced cultures by Ni2+ chelate chromatography and the 
58 
 
radioactive assay of partially purified extracts of the CT overexpression strain (66.4 ± 3.7 
milliunits per mg) versus those of the wild type strain (12.8 ± 0.4 milliunits per mg). The 
partial purification is likely to overstate the wild type activity due to its increased relative 
abundance resulting from the fractionation required [35].   Proper assembly of the 
overexpressed CT was confirmed by assay of CT activity following purification using a 
coupled spectrophotometric assay [8].  The wild type CT tetramer preparation had an 
activity of 29.7 ± 0.6 units per mg, a value in good agreement with those reported 
elsewhere (Fig. 3.2) [8]. 
 
Effects of CT Overexpression on Translation of accA or accD mRNAs Produced by 
T7 Polymerase 
The triple plasmid system of Fig. 3.1 allowed IPTG-dependent manipulation of CT 
tetramer levels whereas T7 polymerase transcription of either accA or accD mRNAs in 
the presence of rifampicin allowed selective assay of translation of these mRNAs by 35S-
methionine labeling. The strains were grown in a chemically defined medium (Materials 
and Methods) lacking sulfur amino acids.  At mid exponential growth phase the cultures 
(containing either the T7 accA or accD expressing plasmid) were split in half.  One half 
received IPTG to induce CT expression while the other half was left unsupplemented.  
Following a period of growth to allow CT overexpression, IPTG was removed and the 
cultures were treated with rifampicin. The cultures were then incubated for 30 min to 
allow full inactivation of the host RNA polymerase and decay of host encoded mRNAs 
[83, 84].  A small portion of each culture was then briefly labeled with 35S-methionine 
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(Fig. 3.3ABC) and the remaining culture volumes were used to assay CT levels by 
western blotting.  The radioactive samples were then processed for SDS-PAGE and the 
intensities of the radioactive bands determined by phosphorimaging.  The lack of labeled 
proteins other than the CT subunits indicates the mRNAs present at the time of rifampicin 
addition had decayed as expected [83, 84].  Note that the AccA and AccD subunits 
produced from the CT minioperon plasmid are of similar size and the loss of resolution 
resulting from transfer from gel to membrane during western blotting obscures the 
separation. (Fig. 3.3C).  
 
The data given in each of the panels A-C of Fig. 3.3 consist of two aligned gels.  The 
upper gel in each panel is the autoradiogram from 35S-methionine labeling whereas the 
lower gel is the western blot quantitation of the level of CT overexpression in the 
remainder of same cultures from 5S-methionine labeling.  Each of the western blot gels 
also contained various levels of purified AccA subunit to serve as an internal quantitation 
standard. Although the similarly sized AccA (35.2 kDa) and AccD (33.2 kDa) subunits 
are resolved on the autoradiograms due to the addition of a thrombin site on the T7 
controlled subunits, the lack of thrombin site and diffusional spreading of the bands 
during the transfer step of western blotting results in merging of the two bands of the CT 
tetramer.    Therefore, the AccA subunit expressed alone from the T7 promoter plasmid 
was also detected by western blotting as a band that migrated slower than the merged CT 
bands due to the thrombin tag. 
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Interpretation of these experiments was straightforward.  As depicted in the cartoon of 
Fig. 3.1B, if translational repression is exerted, the high levels (7 to 27-fold) of CT 
resulting from IPTG induction should decrease the levels of radioactive AccA or AccD 
synthesized, whereas in the absence of translational repression, the levels of labeled 
protein would be unaffected by the amount of CT tetramer present.  I observed no visible 
decrease in the synthesis of radioactive AccA (Fig. 3.3A lanes 5-7) or AccD (Fig. 3.3A 
lanes 8-10) in the presence of the high levels of CT engendered by IPTG induction. 
Quantitation of these data (Fig. 3.3D) indicate that elevated levels of the CT (AccA2-
AccD2) tetramer did not repress translation of the accA and accD mRNAs.  
 
In Fig. 3.3B and C I performed experiments to guard against indirect effects of my 
experimental protocol. I constructed a plasmid that expressed CT tetramers containing an 
AccD subunit lacking the zinc finger moiety.  Such mutant CT tetramers are reported to 
lack nucleic acid binding ability and to be severely deficient in CT activity [62]. In 
agreement with the prior report I purified the mutant CT tetramers and found only a 
barely detectable CT activity (0.3 ± 0.1 units per mg).  The experiment of Fig. 3.3A was 
repeated with the plasmid encoding the mutant CT construct (pACS281) and gave 
essentially identical results to those obtained with the active CT (compare Figs. 3.3A and 
B). Quantitation (Fig. 3.3D) showed overproduction of the mutant CT had no effect on 
translation of the accA and accD mRNAs produced by T7 polymerase.  Finally, in Fig. 
3.3C an experiment in the absence of CT overexpression was performed (the empty CT 
expression vector pACS285 was used).  The levels of 35S-methionine labeled AccA and 
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AccD proteins were essentially identical to those obtained in the presence of CT 
overexpression (Fig. 3.3D) 
 
T7 RNA polymerase is known to transcribe at a rate about 5-fold faster than E. coli RNA 
polymerase [14] and this could affect polyribosome formation (although this could be 
offset by the absence of other mRNAs to compete for ribosome binding). A deficiency in 
polyribosome assembly would expose more RNA to CT binding and thus should increase 
the putative translational repression by CT.  Despite this possibility I observed no 
repression of translation of the accA or accD mRNAs. 
 
DISCUSSION 
As outlined previously, transcription and translation are very strongly coupled in bacteria 
and the coupling is maintained by at least two different mechanisms.  I have no discrete 
explanation for the translational repression observed in vitro by Meades et al [62] and the 
lack of such an effect in my in vivo experiments.  However, I do note several 
problematical features of the prior work and describe several of these.  Meades and 
coworkers [62] initiated their studies by showing that CT bound to DNA and that the zinc 
finger structure was required for binding.  They proceeded to find that various RNA 
preparations inhibited DNA binding and stated that the accA and accD mRNAs were 
more effective than other RNA preparations, although no data were given.  However, the 
other RNA preparations tested (a total RNA extract from E. coli and tRNA from yeast) 
would consist of largely double stranded RNA molecules (rRNA and tRNA) and thus 
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were not strictly comparable.  In other work both DNA and RNA were found to inhibit 
CT enzyme activity.  However, accA mRNA was <4-fold more effective in inhibition 
than was a non-ACC mRNA, that of tsf, which encodes a translation elongation factor. 
This weak binding specificity seems insufficient to play a regulatory role given the 
abundance of mRNAs in vivo. To test for translation repression these workers used a 
commercial E. coli in vitro transcription-translation kit (now discontinued by the 
supplier). Unfortunately, the resulting data were not quantitated and as recently pointed 
out [13] these transcription-translation preparations are designed for protein production 
and not properly constituted such that all RNA polymerase molecules are coupled to 
translation and all ribosomes are coupled to nascent mRNAs.  Hence, these systems do 
not accurately mimic the in vivo setting.  Indeed, development of in vitro expression 
system in which translation is strictly coupled to transcription required detailed analysis 
of the intermediate steps of expression and purification of several components [13]. 
Finally, Meades and coworkers [62] reported the interesting result that CT inhibition of 
translation of the accA and accD mRNAs was reversed by addition of acetyl-CoA.  
However, very high acetyl-CoA concentrations were required (~1 mM and these data are 
difficult to interpret because only acetyl-CoA was tested (and not free CoA, malonyl-
CoA or an acyl-CoA unrelated to fatty acid synthesis such as succinyl-CoA). Since CT 
binding of mRNAs was reported to be sensitive to ionic conditions (24), the effects of 
acetyl-CoA could be the result of altering the ionic environment of the system. 
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TABLES AND FIGURES 
 
Table 3.1.  Plasmids used in this work 
Plasmid Relevant characteristics Source or  
Reference 
pACS229 pVIET encoding accA This Work 
pACS230 pVIET encoding AccD This Work 
pACS243 pVIET ∆lacO encoding AccA  This Work 
pACS245 pVIET ∆lacO encoding AccD  This Work 
pACS251 pQE-80-L-Kan encoding AccA This Work 
pACS254 pQE-80-L-Kan encoding AccD This Work 
pACS262 pQE-80-L-Kan encoding AccD and AccA This Work 
pACS263  pQE-80-L-Kan encoding AccA and AccD This Work 
pACS275 pQE-80-L-Kan encoding C-term His-tagged AccD and 
AccA 
This Work 
pACS280 pQE-80-L-Kan encoding C-term His-tagged AccD and 
AccA ∆cat 
This Work 
pACS281 pQE-80-L-Kan encoding C-term His-tagged AccD 
(C27A, C30A)  and AccA ∆cat 
This Work 
pACS285 pQE-80-L-Kan without cat  This Work 
pQE-80-L-
Kan 
T5 Expression Vector Qiagen 
pVIET T7 Expression Vector [41] 
pTARA pBAD33 expressing T7 polymerase [91] 
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Table 3.2.  Oligonucleotide Primers 
5’ accA NdeI GGAATCATATGAGTCTGAATTTCCTTGATTTTGAACA
GC 
3’ accA + HindIII CATGTAAGCTTCCTGGAAAATCCTTCCTTAATCATAG 
5’ accD NdeI GGTCCCATATGAGCTGGATTGAACGAATTAAAAG 
3’ accD + HindIII GACGAAGCTTGAGGAGTGCGTTTGATAATC 
T7 no LacO top CCGGGATCCGCCGGTGCGAAATTAATACGACTCACT
ATAGGGGTCTAGACG 
T7 no LacO 
bottom 
CTAGGCGGCCACGCTTTAATTATGCTGAGTGATATC
CCCAGATCTGCGATC 
5’ SpHI RBS 
accA/accD pQE80 
CACACAGCATGCATTAAAGAGGAGAAATTAACTATG 
5’ Bam AccA CATCACGGATCCATGAGTCTGAATTTCCTTG 
3’ SpH accD GAGCTCGCATGCTTATCAGGCCTCAG 
5’ Bam accD CATCACGGATCCATGAGCTGGATTGAAC 
3’ SpH accA GAGCTCGCATGCGAATTACGCGTAAC 
3’ SacI accA GAGCTCGAGCTCGAATTACGCGTAAC 
3’ SacI accD GAGCTCGAGCTCTTATCAGGCCTCAG 
5’ accD ScaI C 
HIS 
GACATCAGTACTTAAAGAGGAGAAATTAACTATGAG
CTGGATTGAACGAATTAAAAG 
3’ accD ScaI C 
HIS 
CTTATAAGTACTTATTAGTGGTGGTGGTGGTGGTGCT
CGAGGGCCTCAGGTTC 
C27/30A 3 ATAAAACCTGACCGGCGCTATCAGCCTTAG 
C27/30A 5 CTAAGGCTGATAGCGCCGGTCAGGTTTTAT 
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FIG. 3.1. Experimental design.   
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 FIG. 3.1. (cont.) A. The E. coli host strain MG1655 carried three plasmids. The color 
of the arrow denotes the RNA polymerase that transcribes the gene(s) of interest. 
These plasmids are:  i) A low copy ColE1 origin kanamycin-resistant plasmid 
encoding the two CT proteins under control of the phage T5 promoter (in blue, 
pACS281) ii) A medium copy number p15A origin chloramphenicol-resistant plasmid 
encoding phage T7 RNA polymerase under control of the arabinose (paraBAD) 
promoter (in blue, pTARA). iii) A low copy number pSC101 origin plasmid encoding 
either AccA or AccD under control of the phage T7 promoter (in red, pACS243 or 
pACS245, respectively).  The phage T5 and araBAD promoters are recognized only 
by the rifampicin-sensitive RNA polymerase of the E. coli host whereas the phage T7 
promoter is recognized only by the rifampicin-insensitive T7 RNA polymerase.  
Cultures carrying the three plasmids were grown to mid-exponential phase and split in 
half.  One half received IPTG to induce CT overexpression whereas the other half 
received no inducer (low expression level denoted by the small dot size). Following 
growth to allow CT accumulation IPTG was removed and the cells were resuspended 
in fresh medium and allowed to resume growth.  Rifampicin was then added to block 
utilization of E. coli promoters and the cultures were incubated to allow degradation 
of nascent host mRNAs.  B. Following incubation a small portion of each culture was 
briefly labeled with 35S-methionine to monitor translation (the proteins are denoted by 
the chain of multicolored shapes) of the accA or accD mRNA produced by T7 RNA 
polymerase to test whether or not the presence of higher concentrations of CT 
tetramers (the small tetrameric shapes) bound the mRNA and inhibited its translation.  
The labeled proteins were then separated by SDS-PAGE and the band intensities 
quantitated using a phosphorimager and cognate software.  The cartoon gels at the 
bottom of the figure give the possible experimental outcomes (AccA and AccD are of 
similar size).  The portions of the cultures that were not exposed to 35S-methionine 
were used to assay CT overexpression by western blotting. 
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FIG 3.2. Activity of the purified CT tetramers. Both N terminally tagged and C 
terminally tagged AccD were tested within the accDaccA mini operon.  The 
C27AC30A double mutant AccD versions of these constructs were also tested. To 
ensure that the AccA2-AccD2 hexa-histidine tagged tetramer being overexpressed was 
active (and hence properly assembled) the protein was purified and the activity was 
assayed.  This also confirms that the zinc finger mutants (denoted D*A) have lost 
>95% of their activity.  The assay proceeded in reverse in a coupled reaction where 
NADH formation was measured spectrophotometrically as described in Material and 
Methods.  The wild type C terminally tagged purified protein had an activity of 29.7 ± 
0.6 units/mg compared with the N terminally tagged which was 10.0± 0.5 units/mg.  
The C27A C30A mutant versions of each had greatly diminished activity at 0.3 ± 0.1 
units/mg for the C terminal tag and 0.5± 0.1 units/mg for the N terminal tag. 
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FIG. 3.3. Overproduction of the wild type CT tetramer and its effect on translation 
of the accA or accD mRNAs. In each of Panels A-C the upper gels show the results of 
35S-methionine labeling (35S-Met) whereas the lower gels are assays of CT 
overexpression by western blotting (WB).  The lanes in each panel of the two gels are in 
strict correspondence.  Note that the loss of resolution resulting from the western blotting 
transfer step obscures separation of the similarly sized AccA (35.2 kDa) and AccD (33.2 
kDa) subunits.  Panel A. Upper gel: 35S-Methionine labeling of AccA (lanes 5-7) or 
AccD (lanes 8-10) expressed from the mRNAs transcribed from the T7 promoter in the 
presence or absence of host RNA polymerase expressed CT overproduction.  The 
labeling of either AccA or AccD with 35S-methionine in the presence of rifampicin was 
following cultures left without induction or induced for CT overproduction with IPTG 
(100 or 500 µM).  The plasmid used for CT overproduction was pACS280 whereas the 
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FIG. 3.3. (cont.) T7 promoter plasmids encoding AccA or AccD were pACS243 or 
pACS245, respectively.  Lower gel: Western blot assays of CT overexpression.  Extracts 
of the unlabeled cultures performed in parallel with the 35S-methionine labeling 
experiments were separated on 12% SDS PAGE gels and subjected to western blotting 
with anti-hexahistidine antibody (Materials and Methods).  CT was expressed from 
plasmid pACS280 without or with induction by IPTG as given.  Either the accA or the 
accD T7 expression plasmid (pACS243 or pACS245, respectively) was present for assay 
of the encoded CT subunit expression by 35S-methionine labeling.  The response of the 
band intensities of the western blot to the levels of purified AccA and the relative CT 
overexpression in the absence or with IPTG induction are shown.  Lanes 1-3 shows 
quantitation standards of decreasing quantities of purified AccA (3.31, 0.882 and 0.441 
µg). Lane 4 shows a control AccA protein produced from a T7 transcript that encodes a 
protein having a thrombin tag adjacent to the hexahistidine tag resulting in a protein that 
migrates more slowly than the AccA species encoded by the CT expression plasmid.  
Basal expression from the T7 promoter produced the AccA subunit present in lanes 5-7 
(migrating slower than the CT complex) and the AccD subunit present in lane 8 (which 
migrates similarly to the CT complex and is thus obscured in lanes 9 and 10).  These 
subunits are unable to form CT tetramers due to the lack of overexpression of the other 
subunit.  Comparison of the intensities of the tetramer bands to that of the “missing” 
subunit (that not present in the T7 expression plasmid) in the lanes that lacked IPTG 
gives a rough estimate of the extent of overproduction. In the uninduced samples tetramer 
expression by the host RNA polymerase was below the level of detection and thus direct 
comparison with the subunit expressed from the T7 expression plasmid gave minimum 
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FIG. 3.3. (cont.) ratios of overexpression for lanes 6-7 and 9-10 of >7-fold, 14-fold, 14-
fold, and 27-fold, respectively.   Panel B.  The effects of overproduction of this mutant 
CT on translation of the accA (lanes 5 and 6) or accD (lanes 7 and 8) mRNAs.  This is an 
experiment similar to that of Panel A except that the CT was expressed from plasmid 
pACS281, which expressed an AccD subunit that lacked zinc finger function due to two 
cysteine to alanine substitutions of residues 27 and 30 [62].  The inducer concentration 
was 100 µM IPTG which gave a minimum overexpression levels of 7-fold (accA 
experiment) and 9-fold (accD experiment).  Lanes 1-3 of the western blot shows the 
purified AccA standard (3.31, 0.882, and 0.441 µg) as well as AccA expressed by T7 
polymerase in Lane 4.  Panel C. This experiment assayed translation of the accA (lanes 5 
and 6) or accD (lanes 7 and 8) mRNAs in the absence of CT overexpression (the empty 
vector plasmid, pACS285, was used) and therefore the proteins labeled with 35S-
methionine are the only ones detected by western blotting.  The four AccA quantitation 
standard lanes were loaded with 3.31, 0.882, 0.441 or 0.221 µg of protein (lanes 1-4). 
Panel D. The relative changes in intensity of the 35S-labeled protein bands from 
uninduced samples and those induced with 100 µM IPTG are given.  No significant 
decreases in 35S-labeled protein levels were found. The fold change values were: 1.16 ± 
0.14, 1.1 ±0.03, 1.1 ±.09, 1.02 ±.066, 1.09 ±.072 and 0.96 ± 0.11, respectively. These 
data were obtained from three biological replicates and are given as standard errors.  D*A 
denotes the CT tetramer containing the mutant (C27A C30A) AccD protein. 
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Chapter Four 
PII REGULATION OF ACC ACTIVITY 
INTRODUCTION 
A new aspect of acetyl-CoA carboxylase (ACC) regulation that has recently been shown 
is the connection between the PII signal transduction proteins and the activity of ACC.  
The PII proteins are widely distributed signal transduction proteins, found in bacteria, 
archaea, and plants. They are regulators sensitive to carbon and nitrogen levels in order to 
affect nitrogen assimilation[68]. In E. coli, PII proteins most directly regulate the 
availability and activity of glutamine synthetase (GlnA), which is a major source of 
nitrogen incorporation[50].  The PII protein can be modified by uridylation. In conditions 
of nitrogen excess, low 2-oxoglutarate (2-OG), and high glutamine, PII remains 
unuridylated and causes the adenylation of glutamine synthetase via adenyltransferase 
(GlnE), leaving it inactive. PII is also able to interact with NRII at this point which 
prevents its interaction with NRI which can turn on expression of many nitrogen 
regulated genes, including glutamine synthetase.  However, when nitrogen and glutamine 
levels are low, and 2-OG is high, PII becomes uridylated by uridyltransferase (GlnD), 
allowing for glutamine synthetase deadenylation and increased expression [50, 68].  This 
complex web of regulators allows for the effective control of nitrogen assimilation, 
primarily through the action of glutamine synthetase. The key to the role of the PII 
proteins in this regulation is its ability to bind the effector molecules 2-OG, ATP, and 
ADP. There are two PII paralogues present in E. coli: GlnB and GlnK [87].  They have 
similar functionalities but GlnB is constitutively expressed while GlnK is not [87]. 
72 
 
 
In an effort to identify more targets of the PII protein in Arabidopsis chloroplasts, Feria 
Bourrellier et al. performed a PII affinity pull down experiment[29].  They were able to 
identify biotin carboxyl carrier protein (BCCP) from the plant plastid ACC as well as 
three other biotin/lipoyl domain fragments.  These proteins bound in an Mg-ATP 
dependent fashion and were eluted with treatment with 2-OG.  In ACC activity assays 
they discovered that the presence of the PII protein inhibited ACC which was further 
relieved by the addition of either 2-OG, oxaloacetic acid (OAA), or pyruvate [29]. Given 
the close relation between plant plastid fatty acid synthetic enzymes and their bacterial 
counterparts it seemed reasonable that this effect would be present in E. coli.  This 
chapter describes the preliminary results of the E. coli primary PII protein, GlnB, to act as 
a regulator of ACC activity in my in vitro studies. I have purified both PII proteins of E. 
coli, GlnB and GlnK, and used them to test for inhibition of ACC activity.  The ACC 
activity was assayed by using a strain carrying a plasmid which overexpresses all four 
subunits of ACC, this allows for measured activity from crude extract.  I report that GlnB 
does modulate ACC to approximately 50% activity in good agreement with the plant 
plastid study.  This is in turn mostly alleviated by the addition of 2-OG, although not by 
pyruvate, the other metabolite noted in the plant plastid study. 
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MATERIALS AND METHODS 
Plasmid Constructions 
Plasmid pACS234 was created by amplifying E. coli genomic DNA with primers 5’ 
glnKNdeI Nterm and 3’ glnK HinDIII Nterm using Pfu polymerase(Thermo Scientific).  
This generated a PCR product encoding the native E. coli glnK gene with an NdeI and 
HindII restriction site.  This PCR product along with expression vector pET28b were 
both digested with restriction enzymes NdeI and HindIII.  The vector and insert were 
then ligated together with T4 ligase (NEB) to generate an N-terminally hexahistidine 
tagged GlnK expressing vector.  Plasmid pACS236 was created similarly but utilizing 
primers 5’ glnB BspHI and 3’ glnB BspHI.  This generated a C-terminally hexahistidine 
tagged GlnB expression vector. 
 
Strain Construction 
In order to purify the necessary proteins free of either PII protein it was necessary to 
knock out the native copies of the glnB and glnK genes. A linear fragment of DNA was 
generated by PCR using the primers 5’ glnK KO and 3’ glnK KO and the template 
plasmid pKD3[20]. The resulting DNA fragment contained a chloramphenicol resistance 
cassette flanked by FLP recognition target sites along with sequences in the primers 
homologous to the 5’ and 3’ ends of glnK. This was transformed into the strain MG1655 
which contained the temperature sensitive plasmid pKD46[20] which expresses λ red 
recombinase. The cells were made competent after the strain had been grown at the 
permissive temperature (30° C) with arabinose to induce the expression of the λ red 
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recombinase. The transformed cells were plated and selected for chloramphenicol 
resistance indicating that the resistance cassette had replaced the glnK gene through 
recombination to generate strain AS125. The knockout construct was verified by external 
primers glnK check for and glnK check rev. To create the glnB knockout the same 
process was followed but the linear PCR fragment was generated with primers 5’glnB 
KO and 3’ glnB KO and the template used was pKD4[76].  This generated a kanamycin 
resistance cassette flanked by FLP recognition target sites and the homologous ends of 
glnB. The transformed strain was selected for kanamycin resistance and the resulting 
knockout strain AS127 was confirmed using external primers glnB check for and glnB 
check rev. 
 
The expression strain AS300 was created by moving each of the gene knockouts from 
strains AS125 and AS127 and into expression strain BL21*(Life Technologies) through 
P1 transduction.  P1 phage was grown on each of the knock out strains to generate a 
phage lysate.  The strains AS125 and AS127 were each grown in LB containing 5mM 
MgCl2 and 10 mM CaCl2.  When the cultures reached an optical density (600 nm) of 0.1 
they were each inoculated with stock P1 lysate. The cultures were grown for 2-4 hours 
more until lysis was evident by clearing of the turbid culture.  Chloroform was added and 
the phage lysates were spun down and the supernatant transferred to a fresh tube.  These 
lysates were then used to sequentially transduce the gene knock outs into the BL21* 
strain.  The resistance cassette was selected for and the strain restreaked prior to the next 
round of transduction and selection for the other cassette.  The resulting strain genotype 
was BL21* with ΔglnB::kan ΔglnK::cmr.  The resistance cassettes were then removed in 
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order to facilitate transformation with one of the expression plasmids.  The strain was 
transformed with temperature sensitive plasmid pCP20 which encodes the λ red 
excisionase gene [20]. After transformation with this plasmid at the permissive 
temperature the strains were restreaked at the non-permissive temperature and tested for 
the loss of the resistance cassettes.  Additionally they were checked with the external 
check PCR primers as before.  The resulting strain was AS300 with the ΔglnB Δglnk 
genotype in a BL21* background. 
 
Overexpression and Purification of PII Proteins and Preparation of ACC Extracts 
The PII proteins were purified similar to previous studies [80].  Strain AS300 
transformed with either pACS234 or pACS236 were grown in 2 liters of LB media at 
37°C until OD 0.4 was reached.  Then the culture was supplemented with 0.5 mM IPTG 
and shifted to 24°C for approximately 18 hours.  The cells were then harvested by 
centrifugation and frozen at -80°C for storage. The cell pellet was resuspended as a 50 
fold concentrate in lysis buffer (50 mM Tris-HCl,(pH 7.5) 150 mM NaCl, 10mM 
imidazole, and 0.1% β-ME) and then passage through a French pressure cell multiple 
times.  The cell lysates were then centrifuged to separate cellular debris from soluble 
protein.  Qiagen Ni-NTA slurry was then added to the cleared lysate and the mixture was 
placed on a roller drum at 4° C for 2 hours. The mixture was then loaded on to a gravity 
column and the flow through collected.  The column was then washed with three volumes 
wash buffer (50mM Tris-HCl pH 7.5, 1M NaCl, and 35mM imidazole).  The protein was 
eluted in 50 mM Tris-HCl pH 7.5, 150 mM NaCl, and 300 mM imidazole. The eluted 
fractions were analyzed by SDS PAGE and the appropriate ones combined and then 
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dialyzed against similar buffer excluding imidazole.  The final volume of purified protein 
was then concentrated using an Amicon Ultra centrifugal filter unit. 
 
For the ACC enzyme assay it was necessary to overproduce all subunits of ACC for 
measurable activity.  The plasmids pMSD8 [30] which expresses all four subunits of 
ACC was transformed into AS300 along with pREP4 (Qiagen) which constitutively 
expresses the lac repressor to prevent uninduced overexpression.  One liter of LB media 
was inoculated with this strain and grown until OD 0.5 where it was supplemented with 1 
mM IPTG.  The cells were allowed to grow for an additional 4 hours after which they 
were chilled and spun down and stored at -80°C.  The cell extracts were prepared by 
resuspension in a minimal volume of 2 mM potassium phosphate buffer (pH 7.0) 
followed by disruption by multiple passages through a French pressure cell [22].  The cell 
extract was spun down and the supernatant reserved.  The supernatant was then 
concentrated using an Amicon micro concentrator. 
 
14C ACC Activity Assay 
The ACC activity in the presence and absence of PII proteins was determined by assay of 
NaH14CO3 incorporation into acid stable malonyl-CoA [22, 29, 67].  The 0.2 mL reaction 
volume contained: 100 mM Tris pH 8.0, 50 mM KCl, 3mM ATP, 6 mM MgCl2, 5 mM 
DTT, 0.5 mM acetyl-CoA, 30 mM NaH13CO3, up to 500 µg ACC extract, and up to 200 
µM PII protein.  The reaction was initiated with enzyme extract and allowed to proceed 
for 20 min at 30°C. The reaction was terminated by the addition of 50 µL of 6M HCl and 
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125 µL of the reaction mixture was spotted on to a 3mm Whatman disc and allowed to 
dry.  The dried disc was then measured by scintillation count to determine the activity. 
Additional components were tested as specified in the figures. 
 
RESULTS 
ACC Overexpression 
In a previous study by Davis et al. that determined that ACC is the rate limiting factor of 
fatty acid synthesis, the plasmid pMSD8 was created which allowed for the 
overexpression of ACC activity [22]. This is a low copy plasmid in which all four 
subunits: accA, accB, accC, and accD, were cloned and their expression driven by a T7 
promoter.  Without the overexpression plasmid the activity of wild type E. coli extracts 
was very difficult to measure [22].  This was unlike the plant chloroplast fractions tested 
by Feria Bourrellier et al. as these fractions were able to give adequate activity without 
overexpression [29]. The pMSD8 plasmid was transformed into AS300 along with 
pREP4, a compatible plasmid encoding lacI which aided in the plasmid stability.  The 
plasmid combination was used to overexpress all four of the ACC subunits.  The cell 
extracts were prepared as described in the Materials and Methods and examined for ACC 
activity.  Total ACC activity was measured as the incorporation of NaH14CO3 into 
malonyl-CoA in an acetyl-CoA and ATP dependent fashion and quantitated by 
scintillation counting.  Davis et al. showed that without overexpression of all four 
subunits, activity was undetectable in cell extracts. The cell extracts showed appreciable 
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activity in the ACC activity assays dependent on the presence of acetyl-CoA (Fig.4.1 A, 
B). 
 
Inhibition of ACC Activity by GlnB Protein 
The purification of the GlnB and GlnK proteins from E. coli was straightforward.  The 
sequences of each was cloned into expression vector pET28b and the general guidelines 
from previously published purifications were followed as described in the Materials and 
Methods [4, 30, 80].  The assay for ACC activity was carried out similar to the plant 
plastid as well as E. coli ACC experiments [22, 30]. Initial studies were conducted with 
the GlnB protein. The ACC reaction was dosed with an increasing amounts of GlnB, 
which progressively inhibited 14C incorporation until it plateaued at around 50% activity 
with 193 µM GlnB added (Fig. 4.2A).  The 50% maximum inhibition was consistent with 
what was observed in plant plastid ACC activity and their studies determined that this 
inhibition did not change the Km for acetyl-CoA in the reaction consistent with it acting 
as a noncompetitive inhibitor [67]. 
 
As predicted from the previous study, adding increasing amounts of 2-OG was able to 
alleviate the effects of GlnB on ACC activity (Fig. 4.2B). The PII proteins are able to 
bind both ATP and 2-OG independently in a negatively cooperative manner.  The binding 
of 2-OG to GlnB, which exists as a monotrimer or heterotrimer with GlnK [87], must 
interfere with its ability to interact with BCCP which in turn interferes with ACC activity. 
In early experiments, extract containing ACC that was not concentrated/dialyzed showed 
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activity and GlnB inhibition, but lacked release by 2-OG, potentially indicating that other 
signaling molecules may complicate the interaction.  Of the other metabolites shown to 
disrupt the GlnB-BCCP interaction in the previous study, pyruvate did not show the same 
reversal in inhibition as 2-OG and OAA was not tested.  Additionally as shown in the 
plant plastid study biotin was unable to reverse GlnB inhibition, indicating that BCCP 
was not competing for biotin. However this may have served more as a substrate for 
carboxylation.  This would have to be determined by a method that can distinguish 14C-
labeled malonyl-CoA from 14C labeled carboxybiotin. Preliminary results show that the 
GlnK PII protein of E. coli also exhibits inhibition of ACC activity (63% inhibition with 
116 µM) although the reversal by metabolites has yet to be tested. 
 
DISCUSSION 
I have overexpressed and purified the two PII proteins of E. coli.  While they have been 
well characterized for their role in nitrogen assimilation and the signal transduction of 
various biomolecules, their role in ACC and fatty acid synthesis has not been well 
studied.  By using a strain overexpressing all four subunits of ACC I have been able to 
test GlnB for its inhibition of ACC activity by assaying the purified protein with ACC 
extracts.  This down regulation was followed by reversible metabolite control in the 
presence of 2-OG although not with pyruvate (no inhibition release with 1-100 mM) as 
was noted in the plant plastid study (OAA was not tested). These results confirm for E. 
coli what was observed previously in plant plastids.  E. coli differs in that it contains an 
additional PII protein, GlnK.  The two PII proteins of E. coli share a trimeric structure, 
are both 112 residues, and have 67% amino acid identity [50, 87]. GlnK protein was also 
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tested although not extensively and shown to have a similar level of down regulation, 
although metabolite reversal was not tested. 
 
In a more recent study that looked specifically at PII targets in the bacterium 
Azospirillium brasilense, BCCP was also identified in a PII pull down type assay [76].  A. 
brasilense contains two PII proteins, GlnK and GlnZ, in this case GlnZ was used for pull 
down identification.  In order to confirm the bacterial interactions which were assumed 
conserved, they turned to purified E. coli BCCP and GlnK.  Rodrigues et al. found that 
biotinylated BCCP stably bound GlnK in the presence of ATP and 2-OG was able to 
disrupt this binding as expected [76].  Apo-BCCP was unable to bind GlnK and holo-
BCCP complexed with BC resisted binding to GlnK, indicating that they may occupy the 
same binding sites [76].  Interestingly they found no disruption of ACC activity from 
purified GlnK despite the ample evidence of its BCCP binding. 
 
More work will be required to fully understand the role of the bacterial PII proteins in 
ACC activity and fatty acid synthesis.  The definitive answer on whether GlnK is able to 
inhibit ACC activity consistent with its holo-BCCP binding will have to be examined 
with concurrent GlnB assays for comparison.  The ability of GlnB to bind to holo-BCCP, 
although indicated in the plant plastid study will also have to be determined for E. coli.  
The fact that the two E. coli PII proteins play similar roles and their ability to form 
heterotrimers to allow for activity modulation[87] will also need to be examined in the 
context of ACC activity.  Overall, it is still not clear if the role of PII in fatty acid 
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synthesis is just in the regulation of ACC activity or potentially that of accB and accC 
transcription, which is somehow regulated by the BCCP N-terminal region [43]. 
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TABLES AND FIGURES 
 
Table 4.1.  Primers used in this work 
5’ glnB KO TGGAAACATCCGGCAACCCTTGACGCGGTTTAAATTGCC
GCGTCGTCCTCtgtgtaggctggagctgcttcga 
3’ glnB KO GTTACGTTTAGCAGATCAAAAGACAGGCGACCTTTTCAA
GGAATAGCATGcatatgaatatcctccttag 
5’ glnK KO TTCTTCGTGTAGCAGAACCATTACCGAATTCTGACCGGA
GGGGATCTATGtgtgtaggctggagctgcttcga 
3’ glnK KO TTTTCGTTCCTGTTGCTGTGTGCCAGAGATTACAGCGCCG
CTTCGTCGGCcatatgaatatcctccttaag 
5’ glnB BspHI GGAATATCATGAAAAAGATTGATGCGATTATAAAACCC 
glnK check for GCACACCGCTTGCAATACCTTCTT 
glnK check rev AAACGCATTGTCGGCTTTATCGGC 
glnB check for TTCATTACGAATGCTTTGGCCCGC 
glnB check rev ATAAACTGCTTTCCCGACACGAGC 
3’ glnB BspHI CCCTTGACTCGAGTGCAATTGCCGCGTCGTCCTCTTC 
5’ glnKNdeI 
Nterm 
GGGGACATATGAAGCTGGTGACCG 
3’ glnK HinDIII 
Nterm 
GTGTGCAAGCTTTTACAGCGCCGCTTC 
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Table 4.2.  Strains and Plasmids used in this work 
Strain Relevant characteristics Source 
BL21* T7 expression strain Life Technologies 
AS125 ΔglnK::cm  MG1655 This Work 
AS127 ΔglnB::kan  MG1655 This Work 
AS300 ΔglnB Δglnk  BL21* This Work 
Plasmid Relevant characteristics Source 
pET28b T7 expression vector EMDMillipore 
pACS234 pET28b encoding N-term 
His tagged GlnK   
This Work 
pACS236 
 
pET28b encoding C-term 
His tagged GlnB   
This Work 
pKD3 Chloramphenicol 
resistance cassette plasmid 
[20] 
pKD4 Kanamycin resistance 
cassette plasmid 
[20] 
pKD46 λred recombinase 
expression plasmid 
[20] 
pMSD8 accBCDA expression [22] 
pREP4 lac repressor expression 
plasmid 
Qiagen 
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FIG. 4.1. 14C Bicarbonate incorporation into malonyl-CoA. A. Increasing amounts of 
cell extract from a strain overproducing ACC lead to increased activity. As determined in 
Materials and Methods.  B. Overall reaction is Acetyl-CoA dependent. 
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FIG. 4.2. GlnB (PII) inhibits E. coli ACC activity in vitro. A. Purified PII protein 
inhibited ACC activity in a dose dependent manner. The activity is shown as a percent of 
the activity in the control reaction containing no PII (Materials and Methods).  B.  The 
recovery of the ACC enzyme assay is seen here with increasing amounts of 2-OG.  The 
activity is plotted as the percent inhibition relieved by the increasing 2-OG concentrations 
to the assay containing 116 µM GlnB PII protein. 
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FIG. 4.3. Effect of GlnB and 2-OG on the ACC reaction.  (1) Control reaction omitted 
acetyl-CoA. (2) ACC activity with 50 µg ACC extract.  (3) BSA served as a nonspecific 
protein control (although it slightly enhanced activity). (4) Purified PII (GlnB) protein 
was added to the reaction at 116µM and lead to a 40% reduction in ACC activity. (5) 30 
mM 2-OG led to a maximum reaction recovery of 90% of positive control. 
 
 
 
87 
 
Chapter Five 
CONCLUSIONS 
Acetyl-CoA carboxylase is a vital part of the fatty acid synthetic cycle.  It is the first 
committed step and the driver of the rest of the reactions used to produce fatty acids for 
membrane synthesis [22].  The four structural genes encoding the ACC subunits have 
long been discovered, cloned and characterized for their basic functions in this laboratory 
[19].  However, there is still much to be learned about ACC.  Much of the lack of 
understanding in the enzymology of ACC functions is due to the dissociative nature of 
the enzyme complex.  Evidence shows that the entire complex is associated as a whole in 
the cell but the two activities, the BC and CT function can be easily separated and 
individually assayed in vitro [15].  The specific ability of the BC subunits to act 
catalytically as monomers in vitro [77] was the impetus for the studies of Chapter Two, 
where it was determined that although mutant monomeric BC was catalytically active in 
vitro, it could not perform to its full intracellular potential without dimerization [79].  The 
unusual genetic structure and the lack of clear regulation of the ACC enzymes found in E. 
coli and related bacteria was another aspect that needed to be examined.  Results from 
other studies showing a novel method of regulating the two CT subunits [62] were very 
intriguing but closer examination revealed many unresolved issues with the proposed 
model.  This led to the studies presented in Chapter Three.  Here I examined the proposed 
model by replicating it in an in vivo system where the rest of the relevant cellular 
components would be present.  By using a multi promoter system to monitor the over 
expression of full CT tetramers on the translation of individual CT subunit mRNAs (accA 
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and accD) I have shown that this novel model of regulation does not occur. The 
experiments presented in Chapter Four are work based on plant plastid studies which 
showed that the nitrogen sensing PII protein from Arabidopsis bound to BCCP as well as 
other biotin/lipoyl domains of plant chloroplasts[29].  Due to the similar nature of the 
plant and bacterial fatty acid synthetic systems, I wondered if this also occurred in our 
preferred organism, E. coli.  Indeed, one of the E. coli PII proteins, GlnB, was found to 
inhibit ACC enzyme activity.  
 
Biotin carboxylase catalyzes the first part of the overall ACC reaction.  It transfers the 
carboxyl group from free bicarbonate to the BCCP bound biotin moiety. Although BC 
has been found as a dimer in cell extracts and the subunits are interdependent [44], BC 
proteins mutagenized to remain mostly monomeric in solution were found to retain much 
of their catalytic activity when assayed in vitro [77].  The unique structure of the BC 
dimer, having two active sites separate from the dimer interface made this activity 
possible, although contrary to a previous study in which heterodimer active site mutants 
were unable to catalyze the normal activity [44].  The additional context of the rest of the 
ACC complex posited the question of whether these monomer mutant BCs would remain 
relevant in vivo.  To test this I created knockouts of the essential accBC operon which 
were complemented with plasmid borne wild type or dimer mutant accC. The first test 
was whether these dimer mutant plasmids could complement at all compared with the 
wild type expressing plasmid.  These mutants could grow, but only under high levels of 
induction.  The activity as well as the growth phenotypes of strains dependent on mutant 
BCs showed that those mutants more severe in their inability to dimerize required much 
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higher levels of expression than did the less severe mutant as well as the wild type (Fig 
2.4).  When compared with wild type activity, the dimer mutants were very similar in 
assay tests, however the much larger level of overexpression required belied their ability 
to translate this in vitro activity into in vivo activity (Fig 2.5).  This work helped to 
emphasize the importance of the interaction of the whole ACC complex in the cellular 
context.  This study also helps to highlight that while in vitro enzymatic experiments are 
invaluable they are not always reflective of the in vivo conditions. 
 
Carboxyltransferase catalyzes the second part of the overall ACC reaction. It is composed 
of two subunits encoded by accA and accD[55] . The overall structure is a heterotetramer 
of AccA and AccD [7].  Unlike the BC and BCCP genes which exist in an operon, the CT 
structural genes exist on opposite ends of the E. coli chromosome with no clear method 
of regulation identified, although their existence in stoichiometric amounts has been 
confirmed though a variety of methods [42, 47, 56]. Previous studies had noted that the 
zinc finger structure present on AccD, which plays a role in catalytic activity, was also 
able to bind DNA and RNA [62]. Meades and coworkers presented evidence that the 
ability of AccD to bind its own mRNA was a regulatory mechanism to modulate 
expression of both subunits in a translational repression mechanism. It was an attractive 
idea that one subunit be able to regulate both in order to yield stoichiometric production.  
However, there was the issue of the large (500-600bp) size of mRNA template required 
for binding shown in in vitro experiments. There is ample evidence that the naked 
stretches of mRNA of these subunits would be unlikely to exist in the cell thus calling 
into question this method of regulation [34, 82].  This was examined in Chapter Three.  
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Again to see if relevant intracellular conditions would allow this, I designed a multi 
plasmid, dual polymerase expression system to test this method of regulation.  I was able 
to overexpress complete CT tetramer and measure its effects on single subunit mRNA 
translation by monitoring both the tetramer and subunit through different methods 
(western blotting and radiolabeling).  The results were clear, high level overproduction of 
full CT tetramer which was shown active was unable to modulate the production of single 
subunits (Fig 3.3A).  Unlike other bacteria which have arranged all of the ACC genes 
together on their genomes along with many of the fatty acid synthesis genes, E. coli and 
its close relatives have this scattered structure and so the method of regulating these 
genes to produce stoichiometric amounts will remain an area of interest. 
 
Some recent evidence of ACC regulation came about from plant plastid studies using PII 
protein affinity pull down assays.  BCCP was identified as a protein of interest when 
looking for proteins which bound the PII nitrogen signal integrator in an 2-OG regulated 
manner [29].  The relationship between plant plastid and bacterial fatty acid systems is 
relatively close as both function as type II or dissociated systems.  Thus it seemed likely 
that this activity would also be found in E. coli.  Chapter Four details how I purified both 
PII proteins of E. coli, GlnB and GlnK, and was able to test the ability of GlnB to inhibit 
ACC activity using overexpressed ACC cell extract.  GlnB showed inhibition of activity 
and reversal with the addition of 2-OG although not pyruvate as was seen in the plant 
plastids (Fig. 4.3).  A more recent study also examined the role of the PII protein in 
bacterial ACC activity[76].  This study focused on GlnK and its ability to bind BCCP.  
The studies were convincing in their binding experiments, however they were unable to 
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show any reduction of ACC activity as I saw in brief tests of GlnK and more extensively 
in tests involving GlnB.  This interaction is very interesting as it would further link 
nitrogen and carbon regulation.  A more thorough study of both PII proteins separate and 
combined will have to be performed to more convincingly show its role in ACC function. 
 
Through the studies in this thesis I have answered some of the outstanding questions 
surrounding ACC function and regulation.  However, for future studies there remain a 
number of issues to work out.  Although I have shown that BC must exist in dimeric form 
in vivo, there still remains a lack of consensus on the overall structure and stoichiometry 
of the ACC complex.  Previous studies in the Cronan lab have shown that the entire ACC 
complex likely exists as a homodimer of AccC, a heterotetramer of AccA and AccD, all 
associated with four subunits of AccB[15].  A variety of global proteomic and ribosomal 
profiling studies have confirmed that this is the intracellular ratio that these components 
exist [42, 47, 51, 59]. However, a recent crystal structure has resolved a dimer of AccC 
conjugated with two subunits of BCCP [9].  This structure was produced from artificial 
constructs from separate plasmids which may have promoted a 1:1 ratio rather than the 
chromosomal context in which they are cotranscribed in an operon but translated at 
different efficiencies to generate the 2:1 protein ratio that had been previously noted [51, 
54].  Solving the definitive overall structure of ACC has been difficult because while the 
subunits are found associated together, they are not so tightly bound as to prevent 
dissociation upon purification.  The path to resolving this issue is not exact and will most 
likely require new crystallization studies with appropriate subunit stoichiometry. 
Although the studies of Chapter Three determined that translational repression by CT 
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tetramers was not the method of regulation used to generate stoichiometric amounts of 
AccA and AccD, it was unable to determine the true mechanism.  There has been some 
recent insight with double stranded RNA sequencing which has produced pairings which 
may indicate the effects of antisense RNA (asRNA) on the expression of AccD or AccA 
[60].  Very preliminary results indicate that there may be an up regulation of ACC 
activity with the overexpression of an asRNA which may indicate the presence of another 
regulator involved.  Study of this will require determination of the precise asRNA 
expressed as well as the third party regulator, if indeed one is involved.  The exciting 
possibility exists that this may also tie into the regulation of the accBC operon because 
while it has been shown that the level of AccB regulates the operon, this exact 
mechanism is unknown. 
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